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A B S T R A C T
Background
There is controversy as to whether compulsory community treatment (CCT) for people with severe mental illness (SMI) reduces health
service use, or improves clinical outcome and social functioning.
Objectives
To examine the effectiveness of CCT for people with SMI.
Search methods
We searched the Cochrane Schizophrenia Group’s Trials Register and Science Citation Index (2003, 2008, and 2012). We obtained all
references of identified studies and contacted authors where necessary. We further updated this search on the 8 November 2013.
Selection criteria
All relevant randomised controlled clinical trials (RCTs) ofCCTcomparedwith standard care for peoplewith SMI (mainly schizophrenia
and schizophrenia-like disorders, bipolar disorder, or depression with psychotic features). Standard care could be voluntary treatment
in the community or another pre-existing form of compulsory community treatment such as supervised discharge.
Data collection and analysis
Review authors independently selected studies, assessed their quality and extracted data. We used The Cochrane Collaboration’s tool
for assessing risk of bias. For binary outcomes, we calculated a fixed-effect risk ratio (RR), its 95% confidence interval (CI) and, where
possible, the weighted number needed to treat statistic (NNT). For continuous outcomes, we calculated a fixed-effect mean difference
(MD) and its 95% CI. We used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to
create a ’Summary of findings’ table for outcomes we rated as important and assessed the risk of bias of included studies.
Main results
All studies (n=3) involved patients in community settings who were followed up over 12 months (n = 752 participants).
Two RCTs from the USA (total n = 416) compared court-ordered ’Outpatient Commitment’ (OPC) with voluntary community
treatment. OPC did not result in significant differences compared to voluntary treatment in any of the main outcome indices: health
1Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
service use (2 RCTs, n = 416, RR for readmission to hospital by 11-12 months 0.98 CI 0.79 to 1.21, low grade evidence); social
functioning (2 RCTs, n = 416, RR for arrested at least once by 11-12 months 0.97 CI 0.62 to 1.52, low grade evidence); mental state;
quality of life (2 RCTs, n = 416, RR for homelessness 0.67 CI 0.39 to 1.15, low grade evidence) or satisfaction with care (2 RCTs, n =
416, RR for perceived coercion 1.36 CI 0.97 to 1.89, low grade evidence). However, risk of victimisation decreased with OPC (1 RCT,
n = 264, RR 0.50 CI 0.31 to 0.80). Other than perceived coercion, no adverse outcomes were reported. In terms of numbers needed to
treat (NNT), it would take 85 OPC orders to prevent one readmission, 27 to prevent one episode of homelessness and 238 to prevent
one arrest. The NNT for the reduction of victimisation was lower at six (CI 6 to 6.5).
One further RCT compared community treatment orders (CTOs) with less intensive supervised discharge in England and found no
difference between the two for either the main outcome of readmission (1 RCT, n = 333, RR for readmission to hospital by 12 months
0.99 CI 0.74 to 1.32, medium grade evidence), or any of the secondary outcomes including social functioning and mental state. It was
not possible to calculate the NNT. The English study met three out of the seven criteria of The Cochrane Collaboration’s tool for
assessing risk of bias, the others only one, the majority being rated unclear.
Authors’ conclusions
CCT results in no significant difference in service use, social functioning or quality of life compared with standard voluntary care.
People receiving CCT were, however, less likely to be victims of violent or non-violent crime. It is unclear whether this benefit is
due to the intensity of treatment or its compulsory nature. Short periods of conditional leave may be as effective (or non-effective) as
formal compulsory treatment in the community. Evaluation of a wide range of outcomes should be considered when this legislation is
introduced. However, conclusions are based on three relatively small trials, with high or unclear risk of blinding bias, and evidence we
rated as low to medium quality.
P L A I N L A N G U A G E S U M M A R Y
Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Compulsory community treatment (CCT) for people with severemental health problems is used inmany countries, including Australia,
Israel, New Zealand, the United Kingdom, and the United States. Supporters of this approach suggest that it is less restrictive and
better to compulsorily treat someone in the community than to subject them to repeated hospital admissions. They also argue that
it is effective in bringing stability to the lives of people with severe mental illness. Opponents of CCT fear treatment and support
will be replaced by a greater emphasis on control, restraint, and threat. CCT may also undermine the relationship between healthcare
professionals and patients, leading to feelings of mistrust and being controlled, which may drive people with severe mental illnesses
away from services.
Given the widespread use of such powers, which effectively force people in the community to compulsorily undergo treatment, it is
important to assess the benefits, effectiveness or possible hazards of compulsory treatment.
Update searches for randomised trials were run in 2012 and 2013 and this review now includes three trials with a total of 752 people.
Two of these trials compared a form of CCT called ’Outpatient Commitment’ (OPC) versus standard care and the third trial compared
a form of CCT called Community Treatment Order to supervised discharge. The review authors rated the quality of evidence for the
main outcomes to be low to medium grade. Results from the trials showed overall CCT was no more likely to result in better service
use, social functioning, mental state or quality of life compared with standard ’voluntary’ care. People receiving CCT were less likely
to be victims of violent or non-violent crime. It is unclear whether this benefit is due to the intensity of treatment or its compulsory
nature. Other than feelings of coercion or being controlled, there were no other negative outcomes. Short periods of conditional leave
may be as effective (or non-effective) as compulsory treatment in the community. However, there is very limited information available,
all results are based on three relatively small trials of low to medium quality, making it difficult to draw firm conclusions, so further
research into the effects of different types of compulsory community treatment is much needed.
Ben Gray, Senior Peer Researcher, McPin Foundation http://mcpin.org/.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
COM PULSORY COM M UNITY TREATM ENT compared with STANDARD CARE for people with severe mental disorders
Patient or population: people with severe mental disorders
Settings: pat ients in community sett ings
Intervention: COMPULSORY COMMUNITY TREATMENT
Comparison: STANDARD CARE
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
STANDARD CARE COM PULSORY COM -
M UNITY TREATM ENT
Health service out-
comes: 1. Readmission
to hospital - by 11-12
months
Study population RR 0.98
(0.79 to 1.21)
416
(2 studies)
⊕⊕©©
low1,2
460 per 1000 451 per 1000
(363 to 557)
M edium risk population
446 per 1000 437 per 1000
(352 to 540)
Health service out-
comes: 2. Compliance
with medication - by
11-12 months
Study population RR 0.99
(0.83 to 1.19)
416
(2 studies)
⊕⊕©©
low1,2
505 per 1000 500 per 1000
(419 to 601)
M edium risk population
554 per 1000 548 per 1000
(460 to 659)
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Patient level out-
comes: 1a. Social func-
tioning: trouble with
police - by 11-12
months - at least one
arrest
Study population RR 0.97
(0.62 to 1.52)
416
(2 studies)
⊕⊕©©
low1,2
158 per 1000 153 per 1000
(98 to 240)
M edium risk population
156 per 1000 151 per 1000
(97 to 237)
Patient level out-
comes: 1a. Social func-
tioning: trouble with
police - by 11-12
months - ever arrested/
picked up by police for
violence against a per-
son
Study population RR 0.82
(0.56 to 1.21)
416
(2 studies)
⊕⊕©©
low1,2
208 per 1000 171 per 1000
(116 to 252)
M edium risk population
156 per 1000 128 per 1000
(87 to 189)
Patient level out-
comes: 1b. Social
functioning: homeless
- by 11-12 months
Study population RR 0.67
(0.39 to 1.15)
416
(2 studies)
⊕⊕©©
low1,2
134 per 1000 90 per 1000
(52 to 154)
M edium risk population
145 per 1000 97 per 1000
(57 to 167)
Patient level out-
comes: 2. Quality of
life: victimisation - by
11-12 months
Study population RR 0.5
(0.31 to 0.8)
264
(1 study)
⊕⊕©©
low1,3
311 per 1000 156 per 1000
(96 to 249)
M edium risk population
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311 per 1000 156 per 1000
(96 to 249)
Patient level out-
comes: 3. Satisfac-
tion with care/ adverse
events: perceived co-
ercion - by 11-12
months
Study population RR 1.36
(0.97 to 1.89)
416
(2 studies)
⊕⊕©©
low1,2
218 per 1000 296 per 1000
(211 to 412)
M edium risk population
227 per 1000 309 per 1000
(220 to 429)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Allocat ion concealment and blinding unclear
2 Only 2 studies, both f rom the United States of America
3 Only 1 study
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B A C K G R O U N D
Description of the condition
Compulsory treatment for people with severe mental disorders in
the community is used in many countries, including Australia,
Israel, New Zealand, the United Kingdom (UK), and the United
States of America (USA) (Wilk 1988; Kanter 1995; Torrey 1995;
McIvor 1998; McIvor 2001). In the USA, the majority of states
have some form of compulsory community treatment (Torrey
1995) and there are similar provisions in Australia, Canada and
New Zealand (Dedman 1990; Mulvany 1993; Torrey 1995; Gray
2001; O’Reilly 2001). Early initiatives in the UK included ex-
tended leave for patients leaving hospital and a ’supervision reg-
ister’ (Sensky 1991; Holloway 1996), with the more recent im-
plementation of legislation for compulsory community treatment
in Scotland, England, and Wales (Lawton-Smith 2008; Wooley
2010).
Supporters of this approach suggest that it is less restrictive to com-
pulsorily treat someone in the community than to subject them
to repeated hospital admissions (Pinfold 2001). They also argue
that it is effective in bringing stability to the lives of people with
severe mental illness (O’Reilly 2001). Opponents of compulsory
community treatment fear treatment and support will be replaced
by a greater emphasis on control, restraint, and threat (Pinfold
2001). They argue that compulsion may be used as an alterna-
tive to intensive case management or assertive community treat-
ment, which may be all that is needed (Swartz 1995). Compulsory
community treatment may also adversely effect the therapeutic
alliance between healthcare professionals and patients and drive
people with severe mental illnesses away from services (Pinfold
2001), although the limited data to date do not suggest that this
has happened (O’Reilly 2001).
Description of the intervention
Extended leave or supervised discharge is applied at the time of
discharge from compulsory inpatient treatment. These methods
are used in Canada (Gray 2001), the UK (Sensky 1991), and
New Hampshire, USA (Torrey 1995). They give mental health
professionals the right to return a patient to hospital against their
wishes if they do not comply with treatment.
Community treatment orders (CTOs) are used in Australia
(Vaughan 2000) and Canada (Gray 2001) and give mental health
professionals the right to place an individual on an order, whether
they are in hospital or not. This is in contrast to extended leave or
supervised discharge, which only applies to patients who are being
discharged from inpatient care (Gray 2001). Community treat-
ment orders are designed to divert people from possibly having to
be admitted as inpatients. In addition, unlike leave, the individual
may not have to meet the same criteria for treatment as an inpa-
tient (Gray 2001). Involuntary outpatient treatment or commit-
ment is the preferred term in the USA and covers court-ordered
community treatment (O’Reilly 2001). In this case, a judge, not
a healthcare professional, decides on the appropriateness of the
order.
The range of different interventions and ways of reporting fre-
quency of use make it difficult to estimate how often compul-
sory community treatment is used. The situation is complicated
by the fact that in some jurisdictions, different forms of commu-
nity treatment such as extended release and involuntary outpatient
treatment exist in parallel. Use varies widely across jurisdictions
with the highest rates being recorded in the Australian state of
Victoria with a prevalence of (98.8 per 100,000). By contrast, in
the USA, involuntary outpatient treatment was only used in ap-
proximately three per 100,000 of the general population, 9.8% of
new outpatient admissions and 7.1% of continuing outpatients
(Ridgely 2001). However, even within the USA, the use of invol-
untary outpatient treatment varied. For instance, survey data from
respondents in 13 states and the District of Columbia indicated
they used it commonly or very commonly, while in a further 21
states, use was rare or very rare. Some of this variation may be
explained by the use of alternative provisions such as extended
release (Torrey 1995). Canadian studies indicate a prevalence of
around 5 per 100,000 of the general population (O’Reilly 2000).
How the intervention might work
Studies indicating limited but improved outcomes in terms of
readmission to hospital, length of stay, and adherence to treat-
ment have often not controlled for selection bias, variations in
treatment, and differing criteria for compulsory treatment in the
community (McIvor 1998). In South Carolina, the duration of
psychosis was an important determining factor for compulsory
treatment in the community (Schied-Cook 1987). In England and
Wales, extended leave has been used as a proxy for compulsory
treatment in the community and researchers have identified both
recent dangerousness and non-adherence as determining factors
for being placed on this provision (Sensky 1991). Community
treatment orders in New South Wales are mostly used for unmar-
ried men with schizophrenia (Vaughan 2000). Involuntary out-
patient treatment in many American states does not include the
power to give medication forcibly in a community setting, but
CTOs in Australasia do. In addition, studies often do not include a
control group to take into account the possibility that participants
were recruited when particularly disturbed and that subsequent
reductions in hospital use may be due to other factors. In one
study with a control group of patients not subject to a compulsory
treatment order, the control group showed a similar reduction in
time in hospital (Bursten 1986).
In England and Wales the extended leave provision of the Men-
tal Health Act has been evaluated as a proxy for the community
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treatment order, although it does not cover compulsory treatment
in the community. One group of researchers found that extended
leave improved adherence, reduced time spent in hospital, and
reduced levels of dangerousness (Sensky 1991). The introduction
of supervised discharge meant that a patient could be conveyed to
a designated location for medical treatment, occupation, or train-
ing but was still not obliged to accept treatment; this legislative
measure has never been formally evaluated.
Why it is important to do this review
Even when studies have used controls, it is difficult to know
whether to attribute any improvement to compulsory commu-
nity treatment, or to the non-specific effects of increased contact
with healthcare professionals (Swartz 1995; Torrey 1995; Geller
1998; Swartz 1999). A research group found that although pa-
tients who received prolonged involuntary community treatment
had reduced hospital readmissions and bed-days, it was difficult
to separate out how much of the improvement was due to com-
pulsory treatment and how much to intensive community man-
agement (Swartz 1999). In the case of non-randomised designs, a
further difficulty is ensuring that the control group is as severely
ill as the group placed on a community treatment order (Vaughan
2000).
In summary, it remains unclear whether compulsory community
treatment can improve patient outcome or reduce health service
use. Given the widespread use of such powers in Australasia, Israel,
North America, and the UK, it is important to assess the benefit
and potential harms of this type of legislation.
O B J E C T I V E S
1. To compare compulsory community treatment of any form
with standard voluntary care.
2. To compare different types of compulsory treatment (see
Types of Compulsory community treatment 1.1 in Types of
interventions). We did not pool data from different studies
unless the types of compulsory community treatment in both
arms of trials closely resembled each other.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered all relevant randomised controlled trials (RCTs),
and conducted economic evaluations alongside the included
RCTs. We excluded quasi-randomised studies, such as those allo-
cating by using alternate days of the week. Where trials were de-
scribed in some way as to suggest or imply that the study was ran-
domised and where the demographic details of each group’s par-
ticipants were similar, we included trials and undertook Sensitivity
analysis to the presence or absence of these data.
Types of participants
We included trials of adults with severe mental illnesses (mainly
schizophrenia and schizophrenia-like disorders, bipolar disorder,
or depression with psychotic features), however diagnosed, who
were managed in a community setting. Substance abuse was not
considered to be a severemental disorder in its own right.However,
studies were eligible if they dealt with people with both diagnoses,
i.e. people with severe mental illness plus substance abuse.
Types of interventions
1. Comparison I: Compulsory community treatment versus
standard care
1.1 Compulsory community treatment
For an intervention to be accepted as compulsory community
treatment, it had to be described in the trial using the following
terms: community treatment order, involuntary outpatient treat-
ment, involuntary outpatient commitment, supervised commu-
nity treatment, extended leave, extended release or supervised dis-
charge.
1.2 Standard care
The care that a person would normally receive had they not been
included in the research trial, as long as it did not involve com-
pulsory community treatment in any form.
2. Comparison II: Community treatment orders (CTOs)
versus supervised discharge
Two different types of compulsory treatment, CTOs and super-
vised discharge (see Types of interventions 1.1). We did not pool
data from different studies unless the compulsory treatments in
both arms of the trials closely resembled each other.
Types of outcome measures
We did not plan to report highly specific outcomes (such as, for
example, ’sense of safety’) because multiple testing of sub-compo-
nents of outcome scales carries a risk of type I errors (finding a
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difference when none was present). Outcomes relating to the pro-
cess of the interventions themselves, such as number of outpatient
visits, were not reported (Wagner 2003). We did not consider loss
to follow-up for study purposes to be the same as loss to follow-
up to clinical services, as consent to treatment is not necessarily
the same as consent to participate in a study.
In the original protocol for this study we stated we would group
outcomes into short term (within 12 weeks of the start of ther-
apy), medium term (between 13 to 24 weeks after the beginning
of therapy), and long term (more than 24 weeks after the start of
therapy). Only the Swartz 1999 study reported results of interme-
diate periods of follow-up, and these were not from their RCT.
We have therefore only been able to report outcomes at 11 to 12
months of follow-up.
Primary outcomes
1. Health service contact and utilisation
1.1 Admission to hospital
1.2 Bed-days spent in hospital
2. Social functioning
2.1 Specific - imprisonment, police contact, and arrests
Secondary outcomes
1. Health service contact and utilisation
1.1 Remaining in contact with psychiatric services - leaving the
study early
2. Social functioning
2.1 General
2.2 Specific - employment
2.3 Specific - accommodation status
3. Mental state
3.1 General
3.2 Specific - psychopathology
4. Global state
4.1 General
4.2 Specific
5. Quality of life
5.1 General
5.2 Self-esteem
6. Satisfaction
6.1 Number of needs for care
6.2 Patient satisfaction
6.3 Carer satisfaction
6.4 Perceived coercion
7. Adverse events
7.1 Mortality
8. Economic outcomes
9. ’Summary of findings’ table
Weused theGRADEapproach to interpret findings (Schünemann
2008) and used the GRADE profiler to import data from Review
Manager (Revman) to create ’Summary of findings’ tables. These
tables provide outcome-specific information concerning the over-
all quality of evidence from each included study in the compar-
ison, the magnitude of effect of the interventions examined, and
the sum of available data on all outcomes we rated as important to
patient-care and decision making. We have been able to add more
outcomes to the table and selected the following main outcomes
for inclusion in the ’Summary of findings’ table.
9.1 Health service and utilisation
9.1.1 Admission/readmission to hospital
9.1.2 Bed-days in hospital
9.1.3 Compliance with medication
9.1.4 Number with multiple readmissions by 12 months
9.1.4 Days in community before first admission
9.2 Patient level outcomes
9.2.1 Social functioning: trouble with police, homeless
9.2.2 Quality of life: victimisation
9.2.3 Satisfaction with care; perceived coercion
9.2.4 Mental state: Brief Psychiatric Rating Scale
9.2.5 Global state: Global Assessmant of Functioning
Search methods for identification of studies
Electronic searches
1. Cochrane Schizophrenia Group’s Trials Register
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The Trials Search Coordinator (TSC) searched the Cochrane
Schizophrenia Group’s Registry of Trials (2012 and 8 November
2013) using the following search strategies:
((*treatment* and *order*) or (*involuntar* and *outpatient*) or
(*extend* and *leave*) or (*supervis* and *discharg*) or (*compul-
sor* or *compulsion*)) in Title, Abstract and Keyword Fields of
REFERENCE and (Involuntary* or Outpatient*) in Intervention
Field of STUDY
The Cochrane Schizophrenia Group’s Registry of Trials is com-
piled by systematic searches of major resources (including AMED,
BIOSIS, CINAHL, EMBASE,MEDLINE, PsycINFO, PubMed,
and registries of clinical trials) and their monthly updates, hand-
searches, grey literature, and conference proceedings (see Group
Module). There is no language, date, document type, or publica-
tion status limitations for inclusion of records into the register.
For previous searches, see Appendix 1.
Searching other resources
1. Reference searching
We also inspected the references of all identified studies (including
those rejected from the review) for more studies.
2. Personal contact
We contacted the first author of each included study and known
experts who had published reviews in the field for information
regarding unpublished trials and extra data on the published trials.
Data collection and analysis
For previous data collection and analysis please see Appendix 2.
Selection of studies
For this 2013 update review author SK independently inspected
citations from the new electronic search and identified relevant
abstracts. SK also inspected full articles of the abstracts meeting
inclusion criteria. SK carried out the reliability check of all citations
from the new electronic search.
Data extraction and management
1. Extraction
We extracted data presented only in graphs and figures whenever
possible. When further information was necessary, we contacted
authors of studies in order to obtain missing data or for clarifi-
cation. If studies were multi-centre, where possible, we extracted
data relevant to each component centre separately.
2. Management
2.1 Forms
We extracted data onto standard, simple forms.
2.2 Scale-derived data
We included continuous data from rating scales only if:
a. the psychometric properties of the measuring instrument have
been described in a peer-reviewed journal (Marshall 2000); and
b. the measuring instrument has not been written or modified by
one of the trialists for that particular trial.
Ideally, the measuring instrument should either be i. a self-report
or ii. completed by an independent rater or relative (not the ther-
apist). We realise that this is not often reported clearly; we have
noted whether or not this is the case in Description of studies.
2.3 Endpoint versus change data
There are advantages of both endpoint and change data. Change
data can remove a component of between-person variability from
the analysis. On the other hand, calculation of change needs two
assessments (baseline and endpoint), which can be difficult in
unstable and difficult tomeasure conditions such as schizophrenia.
We decided primarily to use endpoint data, and only use change
data if the former were not available. We combined endpoint and
change data in the analysis as we used mean differences (MD)
rather than standardised mean differences (SMD) throughout (
Higgins 2011, Chapter 9.4.5.2).
2.4 Skewed data
Continuous data on clinical and social outcomes are often not
normally distributed. To avoid the pitfall of applying parametric
tests to non-parametric data, we aimed to apply the following
standards to all data before inclusion:
a) standard deviations (SDs) and means are reported in the paper
or obtainable from the authors;
b) when a scale starts from the finite number zero, the SD, when
multiplied by two, is less than the mean (as otherwise the mean is
unlikely to be an appropriate measure of the centre of the distri-
bution (Altman 1996));
c) if a scale started from a positive value (such as the Positive and
Negative Syndrome Scale (PANSS, Kay 1986), which can have
values from 30 to 210), we planned to modify the calculation
described above to take the scale starting point into account. In
these cases skew is present if 2 SD > (S-S min), where S is the
mean score and S min is the minimum score.
Endpoint scores on scales oftenhave a finite start and endpoint and
these rules can be applied. We planned to enter skewed endpoint
data from studies of fewer than 200 participants in additional
tables rather than into an analysis. Skewed data pose less of a
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problem when looking at mean if the sample size is large; we
entered such endpoint data into syntheses.
When continuous data are presented on a scale that includes a
possibility of negative values (such as change data), it is difficult to
tell whether data are skewed or not. We therefore entered skewed
change data into analyses regardless of size of study.
2.5 Common measure
To facilitate comparison between trials, we intended to convert
variables that can be reported in different metrics, such as days in
hospital (mean days per year, per week or permonth) to a common
metric (e.g. mean days per month).
2.6 Conversion of continuous to binary
Where possible, we made efforts to convert outcome measures
to dichotomous data. This can be done by identifying cut-off
points on rating scales and dividing participants accordingly into
’clinically improved’ or ’not clinically improved’. It is generally
assumed that if there is a 50% reduction in a scale-derived score
such as the Brief Psychiatric Rating Scale (BPRS, Overall 1962)
or the Positive and Negative Syndrome Scale (PANSS, Kay 1986),
this could be considered as a clinically significant response (Leucht
2005; Leucht 2005a). If data based on these thresholds were not
available, we used the primary cut-off presented by the original
authors.
2.7 Direction of graphs
Where possible, we entered data in such a way that the area to
the left of the line of no effect indicated a favourable outcome
for compulsory community and involuntary outpatient treatment.
Where keeping to this made it impossible to avoid outcome titles
with clumsy double-negatives (e.g. ’Not improved’), we reported
data where the left of the line indicates an unfavourable outcome.
This was noted in the relevant graphs.
Assessment of risk of bias in included studies
Review author SK worked independently by using criteria de-
scribed in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011) to assess trial quality. This new set of cri-
teria is based on evidence of associations between overestimate of
effect and high risk of bias of the article such as sequence genera-
tion, allocation concealment, blinding, incomplete outcome data
and selective reporting.
Where inadequate details of randomisation and other characteris-
tics of trials were provided, we contacted authors of the studies in
order to obtain additional information.
We have noted the level of risk of bias in both the text of the review
and in the Summary of findings for the main comparison.
Measures of treatment effect
1. Binary data
For binary outcomes we calculated a standard estimation of the
risk ratio (RR) and its 95% confidence interval (CI). It has been
shown that RR is more intuitive (Boissel 1999) than odds ratios
and that odds ratios tend to be interpreted as RR by clinicians
(Deeks 2000). The Number Needed to Treat/Harm (NNT/H)
statistic is intuitively attractive to clinicians but needs to be inter-
preted with caution (Hutton 2009). For binary data presented in
the ’Summary of findings’ table/s, where possible, we calculated
illustrative comparative risks.
2. Continuous data
For continuous outcomes we estimatedmean difference (MD) be-
tween groups. We preferred not to calculate effect size measures
(standardised mean difference (SMD)). However, if scales of very
considerable similarity were used, we presumed there was a small
difference in measurement, calculated effect size, and transformed
the effect back to the units of one or more of the specific instru-
ments.
Unit of analysis issues
1. Cluster trials
Studies increasingly employ ’cluster randomisation’ (such as ran-
domisation by clinician or practice), but analysis and pooling of
clustered data poses problems. Authors often fail to account for in-
tra-class correlation in clustered studies, leading to a ’unit of anal-
ysis’ error (Divine 1992) whereby P values are spuriously low, con-
fidence intervals unduly narrow and statistical significance overes-
timated. This causes type I errors (Bland 1997; Gulliford 1999).
Cluster trials were eligible for inclusion, however, the three studies
identified in our review were randomised by participant, not by
clinician or practice. Had we included cluster trials, where clus-
tering was not accounted for in primary studies, we planned to
present data in a table, with a (*) symbol to indicate the presence
of a probable unit of analysis error. In subsequent versions of this
review, and if relevant, we will seek to contact first authors of stud-
ies to obtain intra-class correlation coefficients (ICCs) for their
clustered data and to adjust for this by using accepted methods
(Gulliford 1999).Where clustering has been incorporated into the
analysis of primary studies, we will present these data as if from a
non-cluster randomised study, but adjust for the clustering effect.
We have sought statistical advice and have been advised that if
the binary data are presented in a report, they should be divided
by a ’design effect’. This is calculated using the mean number of
participants per cluster (m) and the ICC [Design effect = 1+(m-
1)*ICC] (Donner 2002). If the ICC is not reported it will be
assumed to be 0.1 (Ukoumunne 1999).
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If cluster studies are appropriately analysed taking into account
ICCs and relevant data documented in the report, data can be
synthesised with other studies using the generic inverse variance
technique.
2. Cross-over trials
A major concern of cross-over trials is the carry-over effect. It oc-
curs if an effect (e.g. pharmacological, physiological or psycho-
logical) of the treatment in the first phase is carried over to the
second phase. As a consequence, on entry to the second phase
the participants can differ systematically from their initial state
despite a wash-out phase. For the same reason cross-over trials are
not appropriate if the condition of interest is unstable (Elbourne
2002). As both effects are very likely in severe mental illness, had
we included cross-over trials, we planned to use only the data of
the first phase of any cross-over studies.
3. Studies with multiple treatment groups
If we had included any studies that involved more than two treat-
ment arms, if relevant, we planned to present the additional treat-
ment arms in comparisons. If data were binary, we would simply
have added these and combined them within the two-by-two ta-
ble. If data were continuous, we would have combined data fol-
lowing the formula in section 7.7.3.8 (Combining groups) of the
Cochrane Handbook for Systemic reviews of Interventions (Higgins
2011). Where additional treatment arms were not relevant, we
would not have presented these data.
Dealing with missing data
1. Overall loss of credibility
At some degree of loss of follow-up, data must lose credibility (Xia
2009). We chose that, for any particular outcome, should more
than 50% of data be unaccounted for, we would not reproduce
these data or use them within analyses. If, however, more than
50% of those in one arm of a study were lost, but the total loss was
less than 50%, we addressed this within the ’Summary of findings’
table/s by down-rating quality. Finally, we also downgraded quality
within the ’Summary of findings’ table/s should loss be 25% to
50% in total.
2. Binary
In the case where attrition for a binary outcome was between 0%
and 50% and where these data were not clearly described, we
presented data on a ’once-randomised-always-analyse’ basis (an
intention-to-treat analysis). Those leaving the study early are all
assumed to have the same rates of negative outcome as those who
completed, with the exception of the outcome of death and adverse
effects. For these outcomes, the rate of those who stay in the study
- in that particular arm of the trial - were used for those who did
not. We undertook a sensitivity analysis to test how prone the
primary outcomes were to change when data only from people
who completed the study to that point were compared to the
intention-to-treat analysis using the above assumptions.
3. Continuous
3.1 Attrition
In the case where attrition for a continuous outcome was between
0% and 50%, and data only from people who completed the study
to that point were reported, we presented and used these data.
3.2 Standard deviations
If standard deviations (SDs) were not reported, we first tried to
obtain the missing values from the authors. If not available, where
there were missing measures of variance for continuous data, but
an exact standard error (SE) and confidence intervals available for
group means, and either a P value or T value available for dif-
ferences in mean, we calculated them according to the rules de-
scribed in the Cochrane Handbook for Systemic reviews of Inter-
ventions (Higgins 2011): When only the standard error (SE) was
reported, SDs were calculated by the formula SD = SE * square
root (n). Chapters 7.7.3 and 16.1.3 of the Cochrane Handbook for
Systemic reviews of Interventions (Higgins 2011) present detailed
formulae for estimating SDs from P values, T or F values, confi-
dence intervals, ranges or other statistics. If these formulae did not
apply, we calculated the SDs according to a validated imputation
method which is based on the SDs of the other included studies
(Furukawa 2006). Although some of these imputation strategies
can introduce error, the alternative was to exclude a given study’s
outcome and thus to lose information. We nevertheless examined
the validity of the imputations in a sensitivity analysis excluding
imputed values.
3.3 Last observation carried forward
We anticipated that in some studies themethod of last observation
carried forward (LOCF) would be employed within the study
report. As with all methods of imputation to deal with missing
data, LOCF introduces uncertainty about the reliability of the
results (Leucht 2007). Therefore, we intended where LOCF data
were used in the trial, if less than 50% of the data have been
assumed, we would reproduce these data and indicate that they
were the product of LOCF assumptions.
Assessment of heterogeneity
1. Clinical heterogeneity
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We considered all included studies initially, without seeing com-
parison data, to judge clinical heterogeneity. We simply inspected
all studies for clearly outlying people or situations which we had
not predicted would arise. When such situations or participant
groups arose, we fully discussed these.
2. Methodological heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge methodological heterogeneity. We simply
inspected all studies for clearly outlyingmethodswhichwe had not
predicted would arise. When such methodological outliers arose,
we fully discussed these.
3. Statistical heterogeneity
3.1 Visual inspection
We visually inspected graphs to investigate the possibility of sta-
tistical heterogeneity.
3.2 Employing the I2 statistic
We investigated heterogeneity between studies by considering the
I2 method alongside the Chi2 P value. The I2 provides an estimate
of the percentage of inconsistency thought to be due to chance
(Higgins 2003). The importance of the observed value of I2 de-
pends on i. magnitude and direction of effects and ii. strength
of evidence for heterogeneity (e.g. P value from Chi2 test, or a
confidence interval for I2). An I2 estimate greater than or equal to
around 50% accompanied by a statistically significant Chi2 statis-
tic was interpreted as evidence of substantial levels of heterogene-
ity (Higgins 2011). When substantial levels of heterogeneity were
found in the primary outcome, we explored reasons for hetero-
geneity (Subgroup analysis and investigation of heterogeneity).
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results (Egger 1997).
These are described in Section10of theHandbook (Higgins 2011).
We are aware that funnel plots may be useful in investigating
reporting biases but are of limited power to detect small-study
effects. Only three trials were included in this version of the review.
We planned to use funnel plots for outcomes where there were
10 or more studies, or where all studies were of similar sizes. In
other cases, where funnel plots are possible, we would have sought
statistical advice in their interpretation.
Data synthesis
We understand that there is no closed argument for preference for
use of fixed-effect or random-effects models. The random-effects
method incorporates an assumption that the different studies are
estimating different, yet related, intervention effects. This often
seems to be true to us and the random-effects model takes into
account differences between studies even if there is no statistically
significant heterogeneity. There is, however, a disadvantage to the
random-effects model: it puts added weight onto small studies
which often are the most biased ones. Depending on the direction
of effect, these studies can either inflate or deflate the effect size.
We chose the fixed-effect model for all analyses given the similarity
of patients and interventions in each comparison. The reader is,
however, able to choose to inspect the data using the random-
effects model.
Subgroup analysis and investigation of heterogeneity
1. Subgroup analyses - only primary outcomes
1.1 Clinical state, stage or problem
We had hoped to investigate subgroups including different varia-
tions of types of intervention (e.g. CTOs, involuntary outpatient
treatment, involuntary outpatient commitment (OPC) or super-
vised discharge). Because there were never more than two studies
for each outcome, we could not undertake such sensitivity analyses
as we had hoped.
2. Investigation of heterogeneity
If inconsistency was high, we have reported this. First, we inves-
tigated whether data had been entered correctly. Second, if data
were correct, we visually inspected the graph and successively re-
moved outlying studies to see if homogeneity was restored. For
this review we had decided that should this occur with data con-
tributing to the summary finding of no more than around 10% of
the total weighting, we would present data. If not, then we would
not pool data but would discuss issues. We know of no supporting
research for this 10% cut-off, but we used prediction intervals as
an alternative to this unsatisfactory state.
Sensitivity analysis
We applied all sensitivity analyses to the primary outcomes of this
review.
1. Implication of randomisation
We aimed to include trials in a sensitivity analysis if they were de-
scribed in some way so as to imply randomisation. For the primary
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outcomes we included these studies and if there was no substan-
tive difference when the implied randomised studies were added
to those with a better description of randomisation, we entered all
data from these studies.
2. Assumptions for lost binary data
Where assumptions had to bemade regardingpeople lost to follow-
up (see Dealing with missing data), we compared the findings of
the primary outcomes when we used our assumption/s and when
we used data only from people who completed the study to that
point. If there was a substantial difference, we reported results and
discussed them but continued to employ our assumption.
Where assumptions had to be made regarding missing SDs data
(see Dealing with missing data), we compared the findings of the
primary outcomes when we used our assumption/s and when we
used data only from people who completed the study to that point.
A sensitivity analysis was undertaken to test how prone results are
to change when completer-only data only are compared to the
imputeddata using the above assumption. If therewas a substantial
difference, we reported results and discussed them but continued
to employ our assumption
3. Risk of bias
We analysed the effects of excluding trials that were judged to be
at high risk of bias across one or more of the domains of randomi-
sation (implied as randomised with no further details available):
allocation concealment, blinding and outcome reporting for the
meta-analysis of the primary outcome. If the exclusion of trials at
high risk of bias did not substantially alter the direction of effect
or the precision of the effect estimates, thenwe included data from
these trials in the analysis.
4. Imputed values
We also planned to undertake a sensitivity analysis to assess the
effects of including data from trials where we used imputed values
for ICC in calculating the design effect in cluster randomised trials
but this was not required for the current version of the review.
If we noted substantial differences in the direction or precision of
effect estimates in any of the sensitivity analyses listed above, we
did not pool data from the excluded trials with the other trials
contributing to the outcome, but presented them separately.
R E S U L T S
Description of studies
Also see Characteristics of included studies and Characteristics of
excluded studies
Results of the search
Figure 1 gives details of our search results.We found 74 papers that
were potentially relevant in our original search. Later searches iden-
tified six further publications, Of these, we excluded 65 records
because they did not meet our inclusion criteria, lacked relevant
data, or were evaluating different types of treatment such as joint
crisis plans. This left 15 publications covering three studies (Figure
1).
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Figure 1. Study flow diagram of trial selection.
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Included studies
We included three studies involving 752 participants: two studies
from theUSA comparing outpatient commitment (OPC)with en-
tirely voluntary treatment and oneUK study, theOxfordCommu-
nity Treatment Order Evaluation Trial (OCTET) comparing two
types of compulsory community treatment interspaced with vol-
untary care. OCTET randomised patients discharged from hospi-
tal to an experimental group (community treatment order (CTO))
or a control group (extended leave under section 17 of the Mental
Health Act) and compared their outcomes at 12 months (Burns
2013). “Leave of absence” under Section 17 of the Act allows pa-
tients to leave hospital for some hours or days, or even exception-
ally weeks, while still subject to recall.
Excluded studies
We excluded 65 publications. All but two were excluded as they
were not RCTs, did not contain primary data, or were reviews
of intervention studies. Of the two excluded RCTs, one trial was
excluded (Wagner 2003) as it reported outcomes inherent to the
process of OPC, namely the number of outpatient visits for med-
ication review, counselling and case management. The other was
a study of joint crisis plans (Thornicroft 2013).
Risk of bias in included studies
Allocation
Steadman 2001, the New York study, did describe randomisation,
using a random number list to identify assignment to either the
intervention or control group. In this study, a random number
list was generated by computer, which then split 200 numbers be-
tween one group and the other. The printed list was maintained in
the research team’s office in a locked file.When the treatment team
had completed their treatment plan, they called the research team
who checked the computer list to see whether the client was to be
assigned to the experimental or comparison group. In theOCTET
study, consenting participants were randomly assigned (ratio 1:
1) by an independent statistician to be discharged from hospital
either on CTO or Section 17 leave (Burns 2013). Randomisation
used random permuted blocks with lengths of two, four, and six,
and stratified for sex (male or female), schizophrenic diagnosis (yes
or no) and duration of illness (< 2 years or≥ 2 years). Assignments
were enclosed in sequentially numbered, opaque, sealed envelopes
and stored by a researcher independent to the trial team. The de-
tails of the sequence remained unknown to all members of the trial
team until recruitment, data collection, and analyses were com-
pleted. Randomisation took place after consent was obtained and
the baseline interview was done. The envelope was opened on the
day of the interview by the independent researcher after recording
the participant’s trial identification number on the envelope. She
then communicated the randomised allocation to the recruiting
researcher by telephone. Both studies were rated as being of low
risk (Figure 2; Figure 3). Swartz 1999 was stated to be randomised
but did not provide a description of the randomisation method
and was therefore rated unclear (Figure 2; Figure 3).
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study
Blinding
All three studies used self-report measures for at least some of the
outcomes, which are effectively self-blinding so although blindness
was not mentioned in two of the studies (Steadman 2001; Swartz
1999), we rated risk of bias for blinding as unclear. In Burns 2013
the study involved allocation to two different types of legal status.
It was therefore both impossible and unlawful to mask research
assistants, treating clinicians or patients, thus we rated this as high
risk.
Incomplete outcome data
Attrition rates for Steadman 2001 were 45%. In the case of
OCTET, follow-up for the main outcomes reached 100% al-
though data on psychiatric symptoms and the Global Assessment
of Functioning Scale (GAF) were only available on 70% of the
sample. Reporting on numbers leaving the Swartz 1999 study early
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was sometimes unclear.
Selective reporting
We could not use continuous data for several outcomes, as no vari-
ance was reported. In Swartz 1999 data from randomised and non-
randomised analyses were sometimes amalgamated and reported
percentages rather than absolute numbers of people who had been
followed up.We contacted the authors who kindly confirmed that,
at follow-up, there were 114 people in the control group, 102 in
the court-ordered outpatient commitment (OPC) group and 46
who were not randomised. Similarly, the authors of the Steadman
2001 study kindly supplied the additional data for an intention-
to-treat analysis of their paper. Our overall rating was ’unclear’.
Other potential sources of bias
No conflicts of interest were reported in any of the studies. A po-
tential source of bias in the OCTET study was that participants
were only included if they were equally suitable for a relatively
short Section 17 or CTO. Patients who might have especially ben-
efited from a CTO may therefore have been excluded. A further
potential source of bias in the same study was allowing clinicians
to make decisions independent of initial randomisation-whereby
40 participants (25%) allocated to Section 17 were subsequently
placed on a CTO during the study and 35 patients randomised
to CTOs (22%) did not actually receive the intervention. A sen-
sitivity analysis to remove these protocol violations may, in turn,
have left the study underpowered and not removed the possibil-
ity that Section 17 patients swapped to a CTO might have been
more severely ill than those remaining on Section 17 as per the
protocol. There is uncertainty concerning the control condition.
Although the length of initial compulsory outpatient treatment
differed widely between the two groups (medians of 183 versus
eight days), Section 17 patients averaged three months on some
form of compulsory treatment. On the other hand, an alterna-
tive interpretation of this finding is that the controls still spent
the majority of the study in voluntary treatment. A final issue is
generalisability. Around 20% of the participants were ineligible or
refused to take part. These people may have been the most unwell
or lacking in insight, and therefore, the ones most likely to benefit
from CTOs.
Effects of interventions
See: Summary of findings for the main comparison
COMPULSORY COMMUNITY TREATMENT compared
with STANDARDCARE for people with severemental disorders;
Summary of findings 2 COMMUNITY TREATMENT
ORDERS compared with SECTION 17 for people with severe
mental disorders
COMPARISON 1: COMPULSORY COMMUNITY
TREATMENT versus STANDARD CARE
Results are presented as fixed-effect risk ratios (RR) with 95%
confidence intervals (CIs) or fixed-effect mean difference (MD)
with 95% CIs.
1.1 Health service outcomes: 1. Readmission to hospital - by
11-12 months
For this outcome we found two relevant trials (n = 416). There was
no significant difference between compulsory community treat-
ment and standard care (RR 0.98 CI 0.79 to 1.21, Analysis 1.1).
1.2 Health service outcomes: 2. Compliance with
medication - by 11-12 months
For this outcome we found two relevant trials (n = 416). There was
no significant difference between compulsory community treat-
ment and standard care (RR 0.99 CI 0.83 to 1.19, Analysis 1.2).
1.3 Patient level outcomes: 1a. Social functioning: trouble
with police - by 11-12 months
1.3.1 at least one arrest
In this subgroup we found two relevant trials (n = 416). There was
no significant difference between compulsory community treat-
ment and standard care (RR 0.97 CI 0.62 to 1.52, Analysis 1.3).
1.3.2 ever arrested/picked up by police for violence against a
person
In this subgroup we found two relevant trials (n = 416). There was
no significant difference between compulsory community treat-
ment and standard care (RR 0.82 CI 0.56 to 1.21, Analysis 1.3).
1.4 Patient level outcomes: 1b. Social functioning: homeless
- by 11-12 months
For this outcome we found two relevant trials (n = 416). There was
no significant difference between compulsory community treat-
ment and standard care (RR 0.67 CI 0.39 to 1.15, Analysis 1.4).
1.5 Patient level outcomes: 2. Quality of life: victimisation -
by 11-12 months
For this outcomewe only foundone relevant trial (n = 264) (Swartz
1999). Therewas a statistically significant difference between com-
pulsory community treatment and standard care (RR 0.50CI 0.31
to 0.80, Analysis 1.5).
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1.6 Patient level outcomes: 3. Satisfaction with care:
perceived coercion - by 11-12 months
For this outcome we found two relevant trials (n = 416). There was
no significant difference between compulsory community treat-
ment and standard care (RR 1.36 CI 0.97 to 1.89, Analysis 1.6).
1.7 Economics
We identified no directly relevant costings.
1.8 Numbers needed to treat
In terms of numbers needed to treat (NNT), compared to placebo,
it would take 85 OPC orders to prevent one readmission, 27 to
prevent one episode of homelessness and 238 to prevent one arrest.
The NNT for the reduction of victimisation was lower at six (CI
6 to 6.5).
COMPARISON 2: COMMUNITY TREATMENT
ORDERS versus INTERMITTENT SUPERVISED
DISCHARGE (SECTION 17)
2.1 Health service outcomes: 1. Readmission to hospital - by
12 months
For this outcome we only found one relevant trial (n = 333) (Burns
2013). There was no significant difference between community
treatment orders and section17 (RR0.99CI0.74 to 1.32, Analysis
2.1). It was not possible to calculate theNNT/Has the proportions
of readmissions in both groups were identical (36%).
2.2 Health service outcomes: 2.Hospital bed-days
For this outcome we only found one relevant trial (n = 333) (Burns
2013). There was no significant difference between community
treatment orders and section 17 (MD -8.70 CI -30.88 to 13.48,
Analysis 2.2).
2.3 Health service outcomes: 3. Number of readmissions by
12 months
For this outcome we only found one relevant trial (n = 119) (Burns
2013). Therewas a statistically significant difference between com-
munity treatment orders and section 17 (MD -0.20 CI -0.45 to
0.05, Analysis 2.3).
2.4 Health service outcomes: 4. Number with multiple
readmissions by 12 months
For this outcome we only found one relevant trial (n = 333) (Burns
2013). There was no significant difference between community
treatment orders and section17 (RR0.56CI0.27 to 1.17, Analysis
2.4).
2.5 Days in community till first admission
For this outcome we only found one relevant trial (n = 333) (Burns
2013). There was no significant difference between community
treatment orders and section 17 (MD 5.00 CI -21.74 to 31.74,
Analysis 2.5).
2.6 Patient level outcomes: Brief Psychiatric Rating Scale
(BPRS)
For this outcome we only found one relevant trial (n = 234) (Burns
2013). There was no significant difference between community
treatment orders and section 17 (MD -0.10 CI -3.17 to 2.97,
Analysis 2.6).
2.7 Patient level outcomes: Global Assessment of
Functioning Scale (GAF)
For this outcome we only found one relevant trial (n = 237) (Burns
2013). There was no significant difference between community
treatment orders and section 17 (MD -0.70 CI -3.91 to 2.51,
Analysis 2.7).
2.8 Economics
We identified no directly relevant costings.
2.9 Adverse events
There were no data on this outcome.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
COM M UNITY TREATM ENT ORDERS compared with SECTION 17 for people with severe mental disorders
Patient or population: people with severe mental disorders
Settings: pat ients in community sett ings
Intervention: COMMUNITY TREATMENT ORDERS
Comparison: SECTION 17
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
SECTION 17 COM M UNITY TREAT-
M ENT ORDERS
Health service out-
comes: 1. Readmission
to hospital - by 12
months
Study population RR 0.99
(0.74 to 1.32)
333
(1 study)
⊕⊕⊕©
moderate1,2
359 per 1000 356 per 1000
(266 to 474)
M oderate risk population
359 per 1000 355 per 1000
(266 to 474)
Health service out-
comes: 2. Total du-
ration of psychiatric
hospital stays over12
months
The mean health ser-
vice outcomes: 2. total
durat ion of psychiatric
hospital stays over12
months in the interven-
t ion groups was
8.7 lower
(30.88 lower to 13.48
higher)
333
(1 study)
⊕⊕⊕©
moderate1,2
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Health service out-
comes: 3. Number of
readmissions by 12
months
The mean health ser-
vice outcomes: 3. num-
ber of readmissions by
12 months in the inter-
vent ion groups was
0.2 lower
(0.45 lower to 0.05
higher)
119
(1 study)
⊕⊕⊕©
moderate1,2
Health service out-
comes: 4. Number with
multiple readmissions
by 12 months
Study population RR 0.56
(0.27 to 1.17)
333
(1 study)
⊕⊕⊕©
moderate1,2
108 per 1000 60 per 1000
(29 to 126)
M oderate risk population
108 per 1000 60 per 1000
(29 to 126)
Days in community till
1st admission
The mean days in com-
munity t ill 1st admis-
sion in the intervent ion
groups was
5 higher
(21.74 lower to 31.74
higher)
333
(1 study)
⊕⊕⊕©
moderate1,2
Patient level out-
comes: BPRS
The mean patient level
outcomes: BPRS in
the intervent ion groups
was
0.1 lower
(3.17 lower to 2.97
higher)
234
(1 study)
⊕⊕⊕©
moderate1,2
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Patient level out-
comes: GAF 3
The mean patient level
outcomes: GAF in
the intervent ion groups
was
0.7 lower
(3.91 lower to 2.51
higher)
237
(1 study)
⊕⊕⊕©
moderate1,2
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Forty people (25%) allocated to Sect ion 17 were subsequent ly placed on a CTO during the study
2 35 people randomised to CTOs (22%) did not actually receive the intervent ion
3 No adverse events were reported
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D I S C U S S I O N
In spite of the widespread use of compulsory community treat-
ment and the continued controversy as to its effectiveness, we were
struck by the limited number of studies that have been conducted
in this area. We have therefore attempted to draw modest conclu-
sions, based on available evidence, and to highlight areas requiring
further study, rather than draw firm conclusions that may not be
based on evidence of high quality.
This review revealed little evidence for the effectiveness of compul-
sory community treatment in any of the main outcome indices:
health service use, costs, social functioning, mental state, quality
of life or satisfaction with care. We were only able to establish a
statistically significant effect for one outcome, social functioning
(victimisation).
Although we identified 15 papers, these represented only three tri-
als. Two of these were of court-ordered ’Outpatient Commitment’
(OPC) in the USA with limited generalisability to jurisdictions
where compulsory community treatment is ordered by clinicians.
The third trial, from the UK, was a study of clinician-initiated,
rather than court-ordered treatment as in the American RCTs and
thus,more relevant to other jurisdictions such as Australia, Canada
andNewZealand. However, there is controversy as to whether this
was a comparison of a compulsory intervention with voluntary
treatment, or was a comparison of two different types of compul-
sory treatment. Problems common to all three studies included
relatively small numbers of participants and questions concerning
bias. This illustrates the difficult, but not impossible, task of using
trial methods to study the effect of such legislation.
In the case of the North Carolina study (Swartz 1999), the study
was supplemented by follow-up of an additional non-randomised
group of patients with a recent history of violence who were also
placed on OPC. It was sometimes difficult to separate the results
of the randomised trials from the non-randomised study. In the
case of theNewYork study (Steadman 2001), there was a relatively
small number of participants and the suggestion that members
of the control group and their case managers thought that they
were actually on OPC (NASMHPD 2001). These factors would
minimise any effect of the intervention. In addition to the ques-
tion around the voluntary or compulsory nature of the controls
in the OCTET study, the other major issue was that a quarter of
patients did not receive the intervention to which they were ini-
tially randomised. This was because treating physicians were able
tomake clinical decisions irrespective of initial randomisation, and
was necessary for the trial to be lawful.
Summary of main results
All three studies were of patients in community settings who were
followed up over 12 months. Two trials from the USA were of
court-ordered ’Outpatient Commitment’ (OPC) compared with
voluntary community treatment. The third compared clinician-
initiated community treatment orders (CTOs) with another type
of supervised discharge in England.
Comparison 1. Compulsory community treatment
versus standard care
1.1 Health service outcomes
Only data for two health service outcomes (readmission to hospital
and compliance with medication) were usable. In both cases there
were no differences between groups. By one year, people were no
more likely to be readmitted to hospital if they were placed on
OPC than if they had received standard care. Theywere also just as
likely to complywithmedication. It should be noted, however, that
these results are based on two studies only and in one (Steadman
2001) attrition rates were 45%, so no firm conclusions can be
made.
1.2 Patient level outcomes
Four patient level outcomes (troublewith the police, homelessness,
coercion, and victimisation) were presented.
By one year, the number of arrests by police were similar for both
groups and people in the compulsory community treatment group
did not commit any more acts of violence than those in standard
care. A problem with the data in this area was a possibility of se-
lection bias as patients with a history of violence were explicitly
excluded from both trials. This limits their applicability as recent
dangerousness, particularly violence against others, is often the
reason for compulsory treatment in hospital or the community
(Sensky 1991; Lansing 1997). There is also a risk of bias when
outcome data are not assessed blind to group status and the re-
sults of people who were not randomised or post hoc analyses are
included in papers. The number of people who were homeless by
one year was also similar in both groups.
The only significant benefit from compulsory community treat-
ment was for victimisation. People on compulsory community
treatment were less likely to be victims of a violent or non-violent
crime by one year in the North Carolina study (Swartz 1999).
In terms of possible adverse effects of compulsory community
treatment, perceived coercion was higher in the North Carolina
study (Swartz 1999), but not in the one fromNewYork (Steadman
2001). Combining the findings from both studies in a meta-anal-
ysis gave a non-significant result.
2. Comparison II. Compulsory community treatment
versus intermittent supervised discharge (Section 17)
1.1 Health service outcomes
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There were no differences between patients on CTO and super-
vised discharge in terms of readmissions, bed-days or survival in
the community.
1.2 Patient-level outcomes
Similarly there were no differences between the two groups in
terms of psychiatric symptoms or social functioning as measured
by standardised instruments.
Overall completeness and applicability of
evidence
Two trials were of OPC in the USA. This is a court-ordered com-
pulsory treatment plan and the findings may not be applicable
to other jurisdictions where compulsory community treatment is
initiated by clinicians. In addition, both trials explicitly excluded
patients with a history of violence. Although understandable from
an ethical and legal standpoint, this limits applicability, as recent
dangerousness, particularly violence against others, is often the
reason for compulsory treatment in hospital or the community.
The OCTET study was a comparison of two types of clinician-
ordered community treatment, CTOs and supervised discharge
in England. This may be more applicable to other jurisdictions.
However, around 20% of the sample were ineligible or refused
to take part. These people may have been the most unwell or
particularly lacking in insight, and therefore the ones most likely
to benefit from CTOs
Quality of the evidence
This is a difficult area to research using randomised controlled
trials (RCTs) and so all three studies contained a number of po-
tential biases. OCTET met three out of the seven criteria of The
Cochrane Collaboration’s tool for assessing risk of bias, the others
only one, the majority being rated unclear. There was no differ-
ence in these ratings by outcome. One issue in all three RCTS
was selection and blindness bias and consequent applicability to
everyday care. Depending on the study, patients with a history of
dangerousness were excluded and around 20% of eligible patients
lacked capacity to consent to the study, or refused to take part.
This limits their applicability as recent dangerousness, particularly
violence against others, is often the reason for compulsory treat-
ment in hospital or the community (Sensky 1991; Lansing 1997).
Only two of the three studies describe the process of randomisa-
tion in detail (Steadman 2001; Burns 2013 ) There is also a risk
of bias when outcome data are not assessed blind to group status
and the results of people who were not randomised or post hoc
analyses are included in papers. All three studies used included
intention-to-treat analyses for all (Swartz 1999; Burns 2013), or
at least some of the outcomes of interest (Steadman 2001).
In the case of theNorthCarolina study (Swartz 1999), it was some-
times difficult to separate the results of the randomised trial from
those of the follow-up of an additional non-randomised group of
patients with a recent history of violence who were also placed
on OPC. In the case of the New York study (Steadman 2001),
there were a relatively small number of participants and the sug-
gestion thatmembers of the control group and their case managers
thought that they were actually on OPC (NASMHPD 2001).
These factors would minimise any effect of the intervention
There were also fewer data on psychosocial outcomes as measured
by standardised instruments.
All these issues illustrate the difficult, but not impossible, task of
using trial methods to study the effect of such legislation.
Potential biases in the review process
1. Post hoc decisions
We changed the level of acceptable loss to follow-up. We felt that,
in retrospect, the cut-off of 35% was too restricting and changed
this to 50% (see above). We also added an additional comparison
of two different types of compulsory community treatment. We
took both decisions in the light of only finding three studies. We
have tried to present data in a way as to allow the reader to evaluate
the effects of doing this.
2. Authors’ area of interest
The two authors of this review were also authors of some of the
papers considered for inclusion (Preston 2002; Kisely 2004; Kisely
2005; Kisely 2006; Kisely 2007a).We excluded all of these papers.
It is possible that we, through detailed knowledge of these studies
excluded them, but for others, where our knowledge is not first
hand, we allowed inclusion.
Agreements and disagreements with other
studies or reviews
Our findings are consistent with two other independent reviews
of compulsory community treatment, which have all found little
evidence that compulsory community treatment have a positive
effect on outcomes such as hospital admissions, length of stay or
compliance with medication (Ridgely 2001; Churchill 2007).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
1. For people with serious mental illnesses
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Patients and carers should question the rationale for compulsory
community treatment and advocate more effective treatments.
Brief supervised discharge may be as effective (or non-effective) as
formal community treatment orders (CTOs).
2. For clinicians
Clinicians and health service planners who wish to reduce hospi-
tal admissions should consider alternatives with stronger evidence
for effectiveness such as Intensive Case Management (Dieterich
2010).One possible interpretation of the results from theOCTET
study (is that a short period of conditional leave may suffice for
some patients, and should therefore be considered when both
CTO and conditional leave are available.
3. For policy makers
Based on results from this review, there is no strong evidence to
support the claims made for compulsory community treatment
that make it so attractive for legislators. It does not appear to
reduce health service use or improve patients’ social functioning.
It also does not significantly reduce perceived coercion. Lack of
data made it impossible to assess its effect on costs, mental state,
and other aspects of patient/carer satisfaction. Legislation in this
area may detract from the introduction of interventions that are of
benefit to individuals with severe mental disorder such as Intensive
CaseManagement (Dieterich 2010), butwhich aremore expensive
than legislative solutions to the problem. If governments continue
to introduce this type of legislation, without further evidence for
effectiveness, some evaluation of outcome should be included.
Burns et al suggest that more coercive treatments such as CTOs
are no more effective than briefer supervised discharge.
Implications for research
1. General
Greater adherence to CONSORT standards of reporting (Begg
1996; Moher 2001) would have enabled us to include more data
from one of the included studies (Steadman 2001).
2. Specific
In spite of the widespread use of compulsory community treat-
ment, the only studies we could find were two of court-ordered
community treatment (outpatient commitment (OPC)) in the
USA, and one of CTOs in England. There were much less data,
and no randomised trials, of other forms of compulsory commu-
nity treatment. Further research into the clinical effects of differ-
ent types of compulsory community treatment is indicated.
2.1 Types of studies
The trials presented in this review show that this methodology is
difficult, but not impossible, to apply to compulsory community
treatment. It has, however, been argued that the level of difficulty
involved means that further studies using this methodology may
not be feasible (Bindman 2002). The analysis of routine admin-
istrative data sets may be an alternative. Although the analysis of
such data is subject to biases and difficulties of its own, the use of
epidemiological sampling frames that cover all patients placed on
compulsory community treatment would help to minimise selec-
tion or follow-up bias (Preston 2002). In particular, using these
would have meant that people with a history of violence who were
explicitly excluded from both trials could have been included. The
difficulty of such studies is the identification of suitable controls.
Quasi-experimental designs comparing people from jurisdictions
with similar health systems where one allows compulsory com-
munity treatment and the other does not, may be an answer. Re-
gardless of the source, rigorous multivariable statistical controls
are essential (Swanson 2014).
If further RCTs are attempted, all eligible patients should be ran-
domised, with adequate sample sizes, entirely voluntary controls
and minimal protocol violations (Rugkasa 2014).They should ex-
amine multiple outcomes, not simply hospitalisation, and con-
sider if there is an optimum length of treatment for different cases.
In addition to quantitative research, qualitative techniques may
give additional insights into the effect of compulsory commu-
nity treatment on patients, carers, and healthcare professionals
(O’Reilly 2001). We may also need to consider the place of com-
pulsory community treatment in the range of coercive measures
used to improve compliance with treatment, and look at addi-
tional outcomes such as risk reduction (Bindman 2002).
2.2 Setting
Another interesting finding was the absence of any work from
outside the English-speaking world, even though our literature
search was not restricted to publications in English. We do not
know whether this is due to publication bias, or because such
legislation is either absent or accepted without controversy.
2.3 Participants
Further research may determine whether there are particular peo-
ple with specific problems best managed with CTOs.
2.4 Interventions
We require further well-conducted studies to establish whether it
is the intensity of treatment, its compulsory nature or legislative
framework that affects outcomes.
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2.5 Outcomes
Although the outcomes that were recorded were highly appropri-
ate, it was not always possible to include data on psychosocial
outcomes as measured by standardised instruments in the meta-
analyses. Studies should use well-validated instruments to mea-
sure outcome, and should also collect and report categorical and
’count’ data, such as days in hospital. Data should be in a form
that can easily be incorporated into a systematic reviewwithmeans
and standard deviations (or standard errors) of all continuous out-
come variables. In spite of the ethical and practical issues, the ideal
evaluation of CTOs would be RCT comparisons of involuntary
versus voluntary treatment for each different type of compulsory
community treatment given the wide variations across jurisdic-
tions. At present, the only RCT evidence that compares compul-
sory community treatment with voluntary care concerns court-
ordered OPC in the USA. Elsewhere, the OCTET study com-
pared two forms of compulsory community treatment of varying
intensity and duration in England, and there is no RCT evidence
from any other jurisdiction.
A C K N OW L E D G E M E N T S
SK is employed by the University of Queensland, Australia and
previously by Dalhousie University, Canada. LAC is employed by
Capital District Health Authority, Halifax, Canada. The princi-
ple investigators of two groups who conducted RCTs in this area
kindly confirmed that we had all the relevant papers and supplied
additional data.
The Cochrane Schizophrenia Group provides a standard template
for its Methods, which we have used and adapted for this update.
R E F E R E N C E S
References to studies included in this review
Burns 2013 {published data only}
∗ Burns T, Rugkasa J, Molodynski A, Dawson J, Yeeles K,
Vazquez-Montes M, et al. Community treatment orders for
patients with psychosis (OCTET): a randomised controlled
trial. Lancet 2013;381(9878):1627–33.
ISRCTN73110773. 10PRT/0496: Oxford Community
Treatment Order Evaluation Trial (OCTET): a
single-outcome randomised controlled trial of
compulsory outpatient treatment in psychosis. Http://
www.thelancet.com/protocol-reviews/10PRT-0496 2010.
[CRS: 9000100000013971]
ISRCTN73110773. Oxford community treatment order
evaluation trial. http://public.ukcrn.org.uk 2011.
Ryan A, Patel R, Russell L, Turnpenny L, Visser C.
Community treatment orders on trial: the OCTET RCT.
Psychiatrische Praxis 2011;38:1.
Steadman 2001 {published data only}
Steadman HJ. Final Report: Research Study of the New York
City Involuntary Outpatient Commitment Pilot Program.
Delmar, NY: Policy Research Associates Inc., 1998.
∗ Steadman HJ, Gounis K, Dennis D, Hopper K, Roche B,
Swartz M, et al. Assessing the New York City involuntary
outpatient commitment pilot program. Psychiatric Services
2001;52(3):330–6.
Swartz 1999 {published data only}
Compton SN, Swanson JW, Wagner HR, Swartz MS, Burns
BJ, Elbogen EB. Involuntary outpatient commitment and
homelessness in persons with severe mental illness. Mental
Health Services Research 2003;5(1):27–38.
Hiday VA, Swartz MS, Swanson JW, Borum R, Wagner
HR. Impact of outpatient commitment on victimization
of people with severe mental illness. American Journal of
Psychiatry 2002;159:1403–11.
Swanson JW, Borum R, Swartz MS, Hiday VA, Ryan
Wagner H, Burns BJ. Can involuntary outpatient
commitment reduce arrests among persons with severe
mental illness?. Criminal Justice and Behaviour 2001;28(2):
156–89.
Swanson JW, Swartz MS, Wagner HR, Burns BJ.
Involuntary out-patient commitment and reduction of
violent behaviour in persons with severe mental illness.
British Journal of Psychiatry 2000;174:324–31.
Swartz MS, Hiday VA, Swanson JW, Wagner HR, Borum R,
Burns B. Measuring coercion under involuntary outpatient
commitment. Initial findings from a randomised controlled
trial. Research in Community and Mental Health 1999;10:
52–77.
Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday
VA. Effects of involuntary outpatient commitment and
depot antipsychotics on treatment adherence in persons
with severe mental illness. Journal of Nervous and Mental
Disease 2001;189(9):583–92.
Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday
VA, Borum R. A randomised controlled trial of outpatient
commitment in North Carolina. Psychiatric Services 2001;
52(3):325–9.
∗ Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday
VA, Borum R. Can involuntary outpatient commitment
reduce hospital recidivism? Findings from a randomised
trial with severely mentally ill individuals. American Journal
of Psychiatry 1999;156:1968–75.
Swartz MS, Wagner HR, Swanson J, Hiday VA, Burns
BJ. The perceived coerciveness of involuntary outpatient
commitment: findings from an experimental study. Journal
of the American Academy of Psychiatry and the Law 2002;30
(2):207–17.
25Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
References to studies excluded from this review
Bindman 2002 {published data only}
Bindman J. Involuntary outpatient treatment in England
and Wales. Current Opinion in Psychiatry 2002;15:595–8.
Borum 1999 {published data only}
Borum R, Swartz M, Riley S, Swanson J, Hiday VA,
Wagner R. Consumer perceptions of involuntary outpatient
commitment. Psychiatric Services 1999;50(11):1489–91.
Brophy 2006 {published data only}
Brophy LM, Reece JE, McDermott F. A cluster analysis
of people on community treatment orders in Victoria,
Australia. International Journal of Law and Psychiatry 2006;
29(6):469–81.
Burgess 2006 {published data only}
Burgess P, Bindman J, Leese M, Henderson C, Szmukler G.
Do community treatment orders for mental illness reduce
readmission to hospital? An epidemiological study. Social
Psychiatry and Psychiatric Epidemiology 2006;41(7):574–9.
Bursten 1986 {published data only}
Bursten P. Post-hospital mandatory outpatient treatment.
American Journal of Psychiatry 1986;143:1255–8.
Chaimowitz 2004 {published data only}
Chaimowitz GA. Community treatment orders: an
uncertain step. Canadian Journal of Psychiatry 2004; Vol.
49, issue 9:577–8.
Dawson 2006 {published data only}
Dawson J. Fault-lines in community treatment order
legislation. International Journal of Law and Psychiatry
2006;29(6):482–94.
Fernandez 1990 {published data only}
Fernandez GA, Nygard S. Impact of involuntary outpatient
commitment on the revolving-door syndrome in North
Carolina. Hospital and Community Psychiatry 1990;41(9):
1001–4.
Frank 2005 {published data only}
Frank D, Perry JC, Kean D, Sigman M, Geagea K. Effects
of compulsory treatment orders on time to hospital
readmission. Psychiatric Services 2005;56(7):867–9.
Geller 1998 {published data only}
Geller J, Grudzinskas AJJ, McDermeit M, Fisher WH,
Lawlor T. The efficacy of involuntary outpatient treatment
in Massachusetts. Administration Policy and Mental Health
1998;25:271–85.
Gray 2005 {published data only}
Gray JE, O’Reilly RL. Canadian compulsory community
treatment laws: recent reforms. International Journal of Law
and Psychiatry 2005;28(1):13–22.
Greeman 1985 {published data only}
Greeman M, McClellan T. The impact of a more stringent
commitment code in Minnesota. Hospital and Community
Psychiatry 1985;36(9):990–2.
Hiday 1987 {published data only}
Hiday VA, Scheid-Cook TL. The North Carolina
experience with outpatient commitment: a critical appraisal.
International Journal of Law and Psychiatry 1987;10(3):
215–32.
Hiday 1989 {published data only}
Hiday VA, Scheid-Cook TL. A follow-up of chronic
patients committed to outpatient treatment. Hospital and
Community Psychiatry 1989;40(1):52–9.
Hiday 1999 {published data only}
Hiday V, Swartz M, Swanson J, Borum R, Wagner HR.
Criminal victimisation of persons with severe mental illness.
Psychiatric Services 1999;50(1):62–8.
Hunt 2007 {published data only}
Hunt AM, da Silva A, Lurie S, Goldbloom DS. Community
treatment orders in Toronto: the emerging data. Canadian
Journal of Psychiatry. Revue Canadienne de Psychiatrie 2007;
52(10):647–56. [PUBMED: 18020112]
Jethwa 2008 {published data only}
Jethwa K, Galappathie N. Community treatment orders.
BMJ 2008; Vol. 337:613.
Kanter 1995 {published data only}
Kanter A, Aviram U. Israel’s involuntary outpatient
commitment law: lessons from the American experience.
Israel Law Review 1995;29(4):565–635.
Kisely 2004 {published data only}
Kisely SR, Xiao J, Preston NJ. Impact of compulsory
community treatment on admission rates: survival analysis
using linked mental health and offender databases. British
Journal of Psychiatry 2004;184:432–8.
Kisely 2005 {published data only}
Kisely S, Smith M, Preston NJ, Xiao J. A comparison of
health service use in two jurisdictions with and without
compulsory community treatment. Psychological Medicine
2005;35(9):1357–67.
Kisely 2006 {published data only}
Kisely S, Campbell LA, Preston NJ, Xiao J. Can
epidemiological studies assist in the evaluation of
community treatment orders? - The experience of Western
Australia and Nova Scotia. International Journal of Law and
Psychiatry 2006;29(6):507–15.
Kisely 2006a {published data only}
Kisely S, Campbell LA. Community treatment orders for
psychiatric patients: the emperor with no clothes. Canadian
Journal of Psychiatry 2006;51(11):683-5, 691.
Kisely 2007 {published data only}
Kisely S, Campbell LA. Does compulsory or supervised
community treatment reduce ’revolving door’ care?
Legislation is inconsistent with recent evidence. British
Journal of Psychiatry 2007; Vol. 191:373–4.
Kisely 2007a {published data only}
Kisely S, Campbell LA, Scott A, Preston NJ, Xiao J.
Randomized and non-randomized evidence for the effect
of compulsory community and involuntary out-patient
treatment on health service use: systematic review and
meta-analysis. Psychological Medicine 2007;37(1):3–14.
26Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kisely 2013 {published data only}
Kisely S, Preston N, Xiao J, Lawrence D, Louise S, Crowe E,
et al. An eleven-year evaluation of the effect of community
treatment orders on changes in mental health service
use. Journal of Psychiatric Research 2013;47(5):650–6.
[PUBMED: 23415453]
Kisely 2013a {published data only}
Kisely S, Preston N, Xiao J, Lawrence D, Louise S,
Crowe E. Reducing all-cause mortality among patients
with psychiatric disorders: a population-based study.
CMAJ : Canadian Medical Association Journal = Journal
de l’Association Medicale Canadienne 2013;185(1):E50–6.
[PUBMED: 23148054]
Lawton-Smith 2008 {published data only}
Lawton-Smith S, Dawson J, Burns T. Community treatment
orders are not a good thing. British Journal of Psychiatry
2008;193(2):96–100.
Lidz 1999 {published data only}
Lidz CW. Coercion in psychiatric care: what have we
learned from research?. Journal of the American Academy of
Psychiatry & the Law 1998;26(4):631–7.
Link 2011 {published data only}
Link BG, EppersonMW, Perron BE, Castille DM, Yang LH.
Arrest outcomes associated with outpatient commitment
in New York State. Psychiatric Services (Washington, D.C.)
2011;62(5):504–8. [PUBMED: 21532076]
Miller 1982a {published data only}
Miller R, Fiddleman P. Outpatient commitment: treatment
in the least restrictive environment?. Hospital and
Community Psychiatry 1984;35(2):147–51.
Miller 1985 {published data only}
Miller RD. Commitment to outpatient treatment: a
national survey. Hospital and Community Psychiatry 1985;
36(3):265–7.
Muirhead 2006 {published data only}
Muirhead D, Harvey C, Ingram G. Effectiveness of
community treatment orders for treatment of schizophrenia
with oral or depot antipsychotic medication: clinical
outcomes. Australian and New Zealand Journal of Psychiatry
2006;40(6-7):596–605.
Mullen 2006 {published data only}
Mullen R, Dawson J, Gibbs A. Dilemmas for clinicians in
use of Community Treatment Orders. International Journal
of Law and Psychiatry 2006;29(6):535–50.
Munetz 1996 {published data only}
Munetz MR, Grande T, Kleist J, Peterson G. The
effectiveness of outpatient civil commitment. Psychiatric
Services 1996;47(11):1251–3.
NASMHPD 2001 {published data only}
Medical Directors Council of NASMHPD. Technical
Report on Involuntary Outpatient Commitment. http://
www.nasmhpd.org/publicationsmeddir.cfm (accessed 01
May 2010).
NHPF 2000 {published data only}
National Health Policy Forum. Outpatient Commitment
in Mental Health: Is Coercion the Price of Community
Services?. www.nhpf.org/pdfs˙ib/IB757˙OutptMentalH˙7-
11-02.pdf 2000, issue 757:1.
O’Brien 2005 {published data only}
O’Brien AM, Farrell SJ. Community treatment orders:
profile of a Canadian experience. Canadian Journal of
Psychiatry 2005;50(1):27–30.
O’Keefe 1997 {published data only}
O’Keefe C, Potonza DP, Mueser KT. Treatment outcomes
for severely mentally ill patients on conditional discharge to
community-based treatment. Journal of Nervous and Mental
Disease 1997;185(6):409–11.
O’Reilly 2004 {published data only}
O’Reilly R. Why are community treatment orders
controversial?. Canadian Journal of Psychiatry 2004;49(9):
579–84.
O’Reilly 2006 {published data only}
O’Reilly RL, Keegan DL, Corring D, Shrikhande S,
Natarajan D. A qualitative analysis of the use of community
treatment orders in Saskatchewan. International Journal of
Law and Psychiatry 2006;29(6):516–24.
Patel 2008 {published data only}
Patel G. Community Treatment Orders in Victoria: a
clinico-ethical perspective. Australasian Psychiatry 2008;16
(5):340–3.
Preston 2002 {published data only}
Preston N, Kisely S, Xiao J. Assessing the outcome of
compulsory psychiatric treatment in the community:
epidemiological study in Western Australia. BMJ 2002;
324:1244–9.
Ridgely 2001 {published data only}
Ridgely S, Borum R, Pertila J. The effectiveness of involuntary
outpatient treatment. Empiral evidence and the experience of
eight states. California: RAND, 2001.
Rohland 1998 {published data only}
Rohland BM. The role of outpatient commitment in the
management of persons with schizophrenia. Des Moines, IA:
Iowa Consortium for Mental health, 1998.
Romans 2004 {published data only}
Romans S, Dawson J, Mullen R, Gibbs A. How mental
health clinicians view community treatment orders: a
national New Zealand survey. Australian and New Zealand
Journal of Psychiatry 2004;38(10):836–41.
Segal 2006 {published data only}
Segal SP, Burgess PM. Conditional hospital release:
interpreting the message. Psychiatric Services 2006; Vol.
57, issue 12:1810–1.
Segal 2006a {published data only}
Segal SP, Burgess PM. Factors in the selection of
patients for conditional release from their first psychiatric
hospitalization. Psychiatric Services 2006;57(11):1614–22.
27Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Segal 2006b {published data only}
Segal SP, Burgess PM. Effect of conditional release from
hospitalization on mortality risk. Psychiatric Services 2006;
57(11):1607–13.
Segal 2006c {published data only}
Segal SP, Burgess PM. Conditional release: a less restrictive
alternative to hospitalization?. Psychiatric Services 2006;57
(11):1600–6.
Segal 2006d {published data only}
Segal SP, Burgess PM. The utility of extended outpatient
civil commitment. International Journal of Law and
Psychiatry 2006;29(6):525–34.
Segal 2006e {published data only}
Segal SP, Burgess P. Extended outpatient civil commitment
and treatment utilization. Social Work in Health Care 2006;
43(2-3):37–51.
Segal 2008 {published data only}
Segal SP, Burgess PM. Use of community treatment orders
to prevent psychiatric hospitalization. Australian and New
Zealand Journal of Psychiatry 2008;42(8):732–9.
Segal 2009 {published data only}
Segal SP, Preston N, Kisely S, Xiao J. Conditional release
in Western Australia: effect on hospital length of stay.
Psychiatric Services 2009;60(1):94–9.
Sensky 1991 {published data only}
Sensky T, Hughes T, Hirsch S. Compulsory psychiatric
treatment in the community. I. A controlled study of
compulsory community treatment with extended leave
under the Mental Health Act: special characteristics of
patients treated and impact of treatment. British Journal of
Psychiatry 1991;158:792–9.
Swartz 1997 {published data only}
Swartz MS, Burns BJ, George LK, Swanson J, Hiday VA,
Borum R, et al. The ethical challenges of a randomized
controlled trial of involuntary outpatient commitment.
Journal of Mental Health Administration 1997;24(1):35–43.
Swartz 2004 {published data only}
Swartz MS, Swanson JW. Involuntary outpatient
commitment, community treatment orders, and assisted
outpatient treatment: what’s in the data?. Canadian Journal
of Psychiatry 2004;49(9):585–91.
Swartz 2006a {published data only}
Swartz MS, Swanson JW, Kim M, Petrila J. Use of
outpatient commitment or related civil court treatment
orders in five U.S. communities. Psychiatric Services 2006;
57(3):343–9.
Szmukler 2001 {published data only}
Szmukler G, Hotopf M. Effectiveness of involuntary
outpatient commitment. American Journal of Psychiatry
2001;158(4):653–4.
Thornicroft 2013 {published data only}
Thornicroft G, Farrelly S, Szmukler G, Birchwood M,
Waheed W, Flach C, et al. Clinical outcomes of Joint Crisis
Plans to reduce compulsory treatment for people with
psychosis: a randomised controlled trial. Lancet 2013;381
(9878):1634–41. [PUBMED: 23537606]
Van Putten 1988 {published data only}
Van Putten R, Santiago J, Berren M. Involuntary outpatient
commitment in Arizona: a retrospective study. Hospital and
Community Psychiatry 1988;39(9):953–8.
Vaughan 2000 {published data only}
Vaughan K, McConaghy N, Wolf C, Myhir C, Black T.
Community treatment orders: relationship to clinical
care, medication compliance, behavioural disturbance
and readmission. Australian and New Zealand Journal of
Psychiatry 2000;34:801–8.
Wagner 2003 {published data only}
Wagner HR, Swartz MS, Swanson JW, Burns BJ. Does
involuntary outpatient commitment lead to more intensive
treatment?. Psychology, Public Policy and Law 2003;9(1/2):
145–58.
Wales 2006 {published data only}
Wales HW, Hiday VA. PLC or TLC: is outpatient
commitment the/an answer?. International Journal of Law
and Psychiatry 2006;29(6):451–68.
Xiao 2004 {published data only}
Xiao J, Preston NJ, Kisely S. What determines compulsory
community treatment? A logistic regression analysis using
linked mental health and offender databases. Australian and
New Zealand Journal of Psychiatry 2004;38(8):613–8.
Zanni 1986 {published data only}
Zanni G, De Veau L. Inpatient stays before and after
outpatient commitment. Hopsital and Community Psychiatry
1986;37(9):941–2.
Additional references
Altman 1996
Altman DG, Bland JM. Detecting skewness from summary
information. BMJ 1996;313:1200.
Begg 1996
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin
I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF.
Improving the quality of randomized controlled trials. The
CONSORT statement. JAMA 1996;276:637–9.
Bland 1997
Bland JM. Statistics notes. Trials randomised in clusters.
BMJ 1997;315:600.
Boissel 1999
Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F,
Buyse M, et al. The problem of therapeutic efficacy indices.
3. Comparison of the indices and their use [Apercu sur
la problematique des indices d’efficacite therapeutique, 3:
comparaison des indices et utilisation. Groupe d’Etude
des Indices D’efficacite]. Therapie 1999;54(4):405–11.
[PUBMED: 10667106]
Churchill 2007
Churchill R. International experiences of using community
treatment orders. London: Institute of Psychiatry, 2007.
28Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cook 1995
Cook RJ, Sackett DL. The number needed to treat: a
clinically useful measure of treatment effect. BMJ 1995;
310:452–4.
Dedman 1990
Dedman P. Community treatment orders in Victoria,
Australia. Psychiatric Bulletin 1990;14:462–4.
Deeks 2000
Deeks J. Issues in the selection for meta-analyses of binary
data. Proceedings of the 8th International Cochrane
Colloquium; 2000 Oct 25-28; Cape Town. Cape Town:
The Cochrane Collaboration, 2000.
Dieterich 2010
Dieterich M, Irving CB, Park B, Marshall M. Case
management for people with severe mental disorders.
Cochrane Database of Systematic Reviews 2010, Issue 3.
[DOI: 10.1002/14651858.CD000050]
Divine 1992
Divine GW, Brown JT, Frazier LM. The unit of analysis
error in studies about physicians’ patient care behavior.
Journal of General Internal Medicine 1992;7(6):623–9.
Donner 2002
Donner A, Klar N. Issues in the meta-analysis of cluster
randomized trials. Statistics in Medicine 2002;21:2971–80.
Egger 1997
Egger M, Davey Smith G, Schneider M, Minder CE. Bias
in meta-analysis detected by a simple, graphical test Bias
in meta-analysis detected by a simple graphical test by a
simple, graphical test. BMJ 1997;315:629–34.
Elbourne 2002
Elbourne D, Altman DG, Higgins JPT, Curtina F,
Worthingtond HV, Vaile A. Meta-analyses involving cross-
over trials: methodological issues. International Journal of
Epidemiology 2002;31(1):140–9.
Furukawa 2006
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe
N. Imputing missing standard deviations in meta-analyses
can provide accurate results. Journal of Clinical Epidemiology
2006;59(7):7–10.
Gray 2001
Gray J, O’Reilly R. Clinically significant differences among
Canadian mental health acts. Canadian Journal of Psychiatry
2001;46:315–21.
Gulliford 1999
Gulliford MC. Components of variance and intraclass
correlations for the design of community-based surveys
and intervention studies: data from the Health Survey for
England 1994. American Journal of Epidemiology 1999;149:
876–83.
Higgins 2003
Higgins JP, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ 2003;327
(7414):557–60.
Higgins 2008
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions 5.0.1 [updated
September 2008]. The Cochrane Collaboration. Available
from www.cochrane-handbook.org 2008.
Higgins 2011
Higgins JPT, Green S (editors). Cochrane Handbook for
Systematic Reviews of Interventions Version 5.0.2 [updated
September 2011]. The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org..
Holloway 1996
Holloway F. Supervised discharge - paper tiger?. Psychiatric
Bulletin 1996;20:193–4.
Hutton 2009
Hutton Jane L. Number needed to treat and number needed
to harm are not the best way to report and assess the results
of randomised clinical trials. British journal of haematology
2009;146(1):27–30.
Kay 1986
Kay SR, Opler LA, Fiszbein A. Positive and negative
syndrome scale (PANSS) manual. North Tonawanda, NY:
Multi-Health Systems, 1986.
Kay 1987
Kay SR, Fiszbein A, Opler LA. The positive and negative
syndrome scale (PANSS) for schizophrenia. Schizophrenia
bulletin 1987;13(2):261–76. [PUBMED: 3616518]
Lansing 1997
Lansing AE, Lyons JS, Martens LC, O’Mahoney MT, Miller
SI, Obolsky A. The treatment of dangerous patients in
managed care. Psychiatric hospital utilization and outcome.
General Hospital Psychiatry 1997;19(2):112–8.
Leucht 2005
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E,
Engel R. Clinical implications of Brief Psychiatric Rating
Scale scores. British Journal of Psychiatry 2005;187:366–71.
[PUBMED: 16199797]
Leucht 2005a
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E,
Engel RR. What does the PANSS mean?. Schizophrenia
Research 2005;79(2-3):231–8. [PUBMED: 15982856]
Leucht 2007
Leucht S, Engel RR, Bauml J, Davis JM. Is the superior
efficacy of new generation antipsychotics an artifact of
LOCF?. Schizophrenia Bulletin 2007;33(1):183–91.
[PUBMED: 16905632]
Marshall 2000
Marshall M, Lockwood A, Adams C, Bradley C, Joy C,
Fenton M. Unpublished rating scales - a major source
of bias in randomised controlled trials of treatments for
schizophrenia?. British Journal of Pyschiatry 2000;176:
249–52.
McIvor 1998
McIvor R. The community treatment order: clinical and
ethical issues. Austrailian and New Zealand Journal of
Psychiatry 1998;32:223–8.
29Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
McIvor 2001
McIvor R. Care and compulsion in community psychiatric
treatment work. Psychiatric Bulletin 2001;25:369–70.
Moher 2001
Moher D, Schulz KF, Altman D. The CONSORT
statement: revised recommendations for improving the
quality of reports of parallel-group randomized trials. JAMA
2001;285:1987–91.
Mulvany 1993
Mulvany J. Compulsory community treatment:
implications for community health workers. Australian
Journal of Mental Health Nursing 1993;2:183–9.
O’Reilly 2000
O’Reilly R, Keegan D, Elias J. A survey of the use
of community treatment orders by psychiatrists in
Saskatchewan. Canadian Journal of Psychiatry 2000;45:
79–81.
O’Reilly 2001
O’Reilly R. Does involuntary out-patient treatment work?.
Psychiatric Bulletin 2001;25:371–4.
Overall 1962
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale.
Psychological Reports 1962;10:799–812.
Pinfold 2001
Pinfold V, Bindman J. Is compulsory community treatment
ever justified?. Psychiatric Bulletin 2001;25:268–70.
Ridgely 2001
Ridgely S, Borum R, Petrila J Santa Monica,
California, RAND Corporation. Available at URL,
http//www.rand.org/ publications/MR/MR1340/. . The
Effectiveness of Involuntary Outpatient Treatment,
Empirical Evidence and the Experience of Eight States. The
Effectiveness of Involuntary Outpatient Treatment, Empirical
Evidence and the Experience of Eight States. Santa Monica,
California,: RAND Corporation, 2001.
Rugkasa 2014
Rugkasa J, Dawson J, Burns T. CTOs: what is the state of
the evidence?. Social psychiatry and psychiatric epidemiology
2014;Feb 22.:[Epub ahead of print].. [PUBMED:
24562319]
Rust 1989
Rust J, Golonbok S. Modern Psychometrics. London:
Routledge, 1989.
Schied-Cook 1987
Schied-Cook TL. Commitment of mentally ill to outpatient
treatment. Community Mental Health 1987;23:183–9.
Schünemann 2008
Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks
JJ, Glasziou P, et al. Chapter 12: Interpreting results and
drawing conclusions. In: Higgins JPT, Green S editor(s).
Cochrane Handbook for Systematic Reviews of Interventions.
The Cochrane Collaboration, 2008:359–83.
Swanson 2014
Swanson JW, Swartz MS. Why the evidence for outpatient
commitment is good enough. Psychiatric services
(Washington, D.C.) 2014;65(6):808–11. [PUBMED:
24881685]
Swartz 1995
Swartz MS, Burns BJ, Hiday VA, George LK, Swanson J,
Wagner HR. New directions in research on involuntary
outpatient commitment. Psychiatric Services 1995;46:
381–5.
Torrey 1995
Torrey EF, Kaplan RJ. A national survey of the use of
outpatient commitment. Psychiatric Services 1995;46:
778–84.
Ukoumunne 1999
Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC,
Burney PGJ. Methods for evaluating area-wide and
organisation-based intervention in health and health care: a
systematic review. Health Technology Assessment 1999;3(5):
1–75.
Wilk 1988
Wilk RJ. Implications of involuntary outpatient
commitment for community health agencies. American
Journal of Orthopsychiatry 1988;58:580–91.
Wooley 2010
Woolley S. Involuntary treatment in the community: role of
community treatment orders. Psychiatrist 2010;34:441–6.
[DOI: 10.1192/pb.bp.109.028027]
Xia 2009
Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-
Sayeh H, Pinfold V, Takriti Y. Loss to outcomes stakeholder
survey: the LOSS study. Psychiatric Bulletin 2009;33(7):
254–7.
References to other published versions of this review
Kisely 2004
Kisely S, Preston N. Compulsory community treatment
and involuntary outpatient treatment for people
with severe mental disorders. Cochrane Database of
Systematic Reviews 2004, Issue 4. [DOI: 10.1002/
14651858.CD004408.pub2]
Kisely 2005
Kisely S, Campbell LA, Preston N. Compulsory community
and involuntary outpatient treatment for people with severe
mental disorders. Cochrane Database of Systematic Reviews
2005, Issue 3. [DOI: 10.1002/14651858.CD004408.pub2;
PUBMED: 16034930]
Kisley 2011
Kisely SR, Campbell LA, Preston NJ. Compulsory
community and involuntary outpatient treatment for
people with severe mental disorders. Cochrane Database
of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/
14651858.CD004408.pub3]
∗ Indicates the major publication for the study
30Compulsory community and involuntary outpatient treatment for people with severe mental disorders (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Burns 2013
Methods Allocation: randomised (1:1 ratio).
Blindess: not blinded: randomisation involved allocation to two different types of legal
status. It was therefore both impossible and unlawful to mask research assistants, treating
clinicians or patients
Duration: 12 months.
Participants Diagnosis: patients with psychosis discharged from hospital - 84% had schizophrenia -
diagnostic criteria not stated
N = 336 (ITT analysis).
Age: 18 - 65 years.
Sex: 225 M, 111 F.
History: involuntarily admitted to hospital with psychosis and deemed suitable for su-
pervised outpatient care by the treating clinicians.
Exclusion criteria: nil.
Interventions 1. Compulsory community treatment (CCT).
2. Supervised discharge (Section 17 leave): patients allowed to leave hospital for some
hours or days, or even exceptionally weeks, while still subject to recall
Outcomes Service use: readmission to hospital, number of days in psychiatric hospital, number of
readmissions, time to admission
Mental state: BPRS.
Global state: GAF.
Unable to use: loss to care, adherence to prescribed.medication, satisfactionwith services,
engagement with clinical services
Notes ITT analysis.
Both intervention and control groups were subject to some form of compulsory com-
munity treatment for at least part of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Consenting participants were randomly as-
signed (ratio 1:1) by an independent statis-
tician to be discharged from hospital either
on CTO or Section 17 leave. Randomisa-
tion used random permuted blocks with
lengths of two, four, and six, and strati-
fied for sex (male or female), schizophrenic
diagnosis (yes or no) and duration of ill-
ness (<2 years or ≥2 years). Assignments
were enclosed in sequentially numbered,
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Burns 2013 (Continued)
opaque, sealed envelopes and stored by a
researcher independent to the trial team
Allocation concealment (selection bias) Unclear risk The details of the sequence remained un-
known to all members of the trial team un-
til recruitment, data collection, and anal-
yses were completed. Randomisation took
place after consent was obtained and the
baseline interview was done. The envelope
was opened on the day of the interview by
the independent researcher after recording
the participant’s trial identification number
on the envelope. She then communicated
the randomised allocation to the recruiting
researcher by telephone
Blinding (performance bias and detection
bias)
All outcomes
High risk See above - randomisation involved alloca-
tion to two different types of legal status.
It was therefore both impossible and un-
lawful to mask research assistants, treating
clinicians or patients
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was no attrition for the primary out-
come measure, or health service use; out-
come data on psychiatric symptoms and
the GAF were only available on 70% of the
sample
Selective reporting (reporting bias) Low risk
Other bias High risk Other potential sources of bias in the study
included allowing clinicians to make de-
cisions independent of initial randomisa-
tion-whereby 40 patients (25%) allocated
to Section 17 were subsequently placed on
a CTO during the study and 35 patients
randomised to CTOs (22%) did not actu-
ally receive the intervention. A sensitivity
analysis to remove these protocol violations
may, in turn, have left the study underpow-
ered and not removed the possibility that
Section 17 patients swapped to a CTO
might have been more severely ill than
those remaining on Section 17 as per the
protocol. There is uncertainty concerning
the control condition. Although the length
of initial compulsory outpatient treatment
differed widely between the two groups
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Burns 2013 (Continued)
(medians of 183 vs. eight days), the Section
17 group averaged four months on some
formof compulsory treatment. A final issue
is generalisability. Around 20% of the sam-
ple were ineligible or refused to take part.
These participants may have been the most
unwell or insightless, and therefore the ones
most likely to benefit from CTOs
Steadman 2001
Methods Allocation: randomised, described.
Blindness: unclear*.
Duration: 11 months.
Participants Diagnosis: majority had psychosis - diagnostic criteria not stated.
N = 152.*
Age: over 18 years.
Sex: 94 M, 48 F.
History: poor compliance with services when discharged.
Exclusion criteria: history of violence.
Interventions 1. CCT: enhanced service package + intensive, court-ordered compulsory OPC, includ-
ing involuntary medication for people thought by court to lack capacity to give informed
consent. N = 78.
2. Standard care: enhanced service package with inpatient assessment and comprehensive
discharge treatment plan in which patients participated, case management, and oversight
by OPC co-ordinating plan. N = 64.**
Outcomes Service use: number of admissions, compliance with medication.
Social functioning: number of arrests, homelessness.
Satisfaction with care: perceived coercion (MAES).
Unable to use -
Service use: hospitalisation - length of stay (no SD), remaining in contact (leaving the
study early) (data unusable).
Mental state: PANSS (no SD).
Global state: GAF (no SD).
Quality of life: LBQL (no SD).
Adverse effects: various side effects (no SD).
Notes ITT analysis.
* Study did not specifically mention blindness but did use self-report measures for at
least some of the outcomes, which are effectively self-blinding
*142 completed baseline interview, 10 excluded from all reporting
**There was a suggestion that members of the control group and their case managers
thought that they were actually on OPC
Risk of bias
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Steadman 2001 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The study used a random number list to
identify assignment to either the interven-
tion or control group. In this study, a ran-
dom number list was generated by com-
puter, which then split 200 numbers be-
tween one group and the other
Allocation concealment (selection bias) Unclear risk Unclear. The printed list was maintained
in the research team’s office in a locked file.
When the treatment team had completed
their treatment plan, they called the re-
search team who checked the computer list
to see whether the client was to be assigned
to the experimental or comparison group
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No specific mention in the study but did
use self-report measures for at least some
of the outcomes, which are effectively self-
blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk Only between57 and68per cent of the par-
ticipants completed interviews at one, five,
and 11 months after hospital discharge.
Only some outcomes were assessed by ITT
analysis
Selective reporting (reporting bias) Unclear risk Unclear from paper
Other bias Unclear risk Unclear, no conflict of interests reported.
Swartz 1999
Methods Allocation: randomised.
Blindness: not blinded.
Duration: 12 months.
Participants Diagnosis: schizophrenia, schizoaffective disorder or other major psychotic or affective
disorder - diagnostic criteria not stated.
N = 264.*
Age: over 18 years.
Sex: 132 M, 132 F.
History: ill > 1 year, significant functional impairment (NCFAS score >/= 90), intensive
treatment in past 2 years, awaiting period of court-ordered CCT, only included patients
discharged from hospital not those already living in the community.
Exclusion criteria: personality disorder, psychoactive substance use disorder, organic brain
syndrome in absence of primary psychotic ormood disorder, recent serious act of violence
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Swartz 1999 (Continued)
involving injury or use of a weapon.*
Interventions 1. CCT: intensive, court-ordered compulsory OPC. N = 129.
2. Standard care: control group were released fromOPC by notifying the court. N = 135
Outcomes Service use: number of admissions,compliance with medication.
Social functioning: number of arrests, threatening behaviour, homelessness.
Quality of life: victimisation - number of violent or non-violent attacks
Satisfaction with care: perceived coercion (MAES).
Unable to use -
Hospitalisation: length of stay (data unusable).
Leaving the study early (data unusable).
Notes * Data for this review based only on those randomised to treatment groups and only
non-violent participants were randomised
The RCT was supplemented by a non-random post hoc analysis of the intervention
group based on duration of involuntary outpatient treatment. Renewals of CCT were
not randomised for patients who no longer met legal criteria
ITT analysis.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Stated to be randomised but did not de-
scribe process.
Allocation concealment (selection bias) Unclear risk Stated to be randomised but did not de-
scribe process.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No specific mention in the study but used
self-report measures for at least some of the
outcomes, which are effectively self-blind-
ing
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of the identified eligible patients, about
12% refused to participate. Subsequent at-
trition from the study was 18.2% (N = 48)
but bias was minimised by ITT analysis
Selective reporting (reporting bias) Unclear risk Unclear from paper.
Other bias Unclear risk Unclear, no conflicts of interest reported.
BPRS: Brief Psychiatric Rating Scale
CCT - Compulsory community treatment
CTO: community treatment orders
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GAF - Global Assessment of Functioning Scale
ITT - Intent-to-treat
LBQL - Lehman Brief Quality of Life Interview
MAES - MacArthur Modified Admission Experience Survey
NCFAS - North Carolina Functional Assessment Scale
OPC - Outpatient commitment
PANSS - Positive and Negative Syndrome Scale
RCT: randomised controlled trial
SD - Standard deviation
vs: versus
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bindman 2002 Allocation: not randomised, review.
Borum 1999 Allocation: not randomised.
Brophy 2006 Allocation: not randomised, no controls.
Burgess 2006 Allocation: not randomised.
Bursten 1986 Allocation: not randomised.
Chaimowitz 2004 Review: no primary data.
Dawson 2006 Review: no primary data.
Fernandez 1990 Allocation: not randomised, no controls.
Frank 2005 Allocation: not randomised.
Geller 1998 Allocation: not randomised.
Gray 2005 Review: no primary data.
Greeman 1985 Allocation: not randomised.
Hiday 1987 Allocation: not randomised.
Hiday 1989 Allocation: not randomised.
Hiday 1999 Allocation: not randomised.
Hunt 2007 Allocation: not randomised.
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(Continued)
Jethwa 2008 Allocation: not randomised, review.
Kanter 1995 Allocation: not randomised, review.
Kisely 2004 Allocation: not randomised.
Kisely 2005 Allocation: not randomised.
Kisely 2006 Review: no primary data.
Kisely 2006a Review: no primary data.
Kisely 2007 Review: no primary data.
Kisely 2007a Review: no primary data.
Kisely 2013 Allocation: not randomised.
Kisely 2013a Allocation: not randomised.
Lawton-Smith 2008 Review: no primary data.
Lidz 1999 Allocation: not randomised, review.
Link 2011 Allocation: not randomised.
Miller 1982a Allocation: not randomised, before and after design.
Miller 1985 Allocation: not randomised, survey of providers.
Muirhead 2006 Allocation: not randomised, retrospective design.
Mullen 2006 Allocation: not randomised, review.
Munetz 1996 Allocation: not randomised, retrospective design.
NASMHPD 2001 Allocation: not randomised, review.
NHPF 2000 Allocation: not randomised, review.
O’Brien 2005 Allocation: not randomised, no controls.
O’Keefe 1997 Allocation: not randomised, no controls.
O’Reilly 2004 Review: no primary data.
O’Reilly 2006 Qualitative evaluation: not randomised.
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(Continued)
Patel 2008 Review: no primary data.
Preston 2002 Allocation: not randomised.
Ridgely 2001 Allocation: not randomised.
Rohland 1998 Allocation: not randomised.
Romans 2004 Allocation: not randomised.
Segal 2006 Allocation: not randomised.
Segal 2006a Allocation: not randomised.
Segal 2006b Allocation: not randomised.
Segal 2006c Allocation: not randomised.
Segal 2006d Allocation: not randomised.
Segal 2006e Allocation: not randomised.
Segal 2008 Allocation: not randomised.
Segal 2009 Allocation: not randomised.
Sensky 1991 Allocation: not randomised.
Swartz 1997 Allocation: not randomised.
Swartz 2004 Allocation: not randomised.
Swartz 2006a Allocation: not randomised.
Szmukler 2001 No primary data.
Thornicroft 2013 Not a study of compulsory community treatment.
Van Putten 1988 Allocation: not randomised, no controls.
Vaughan 2000 Allocation: not randomised.
Wagner 2003 Allocation: randomised.
Participants: people with schizophrenia, schizoaffective disorder or othermajor psychotic or affective disorders.
Intervention: 1. CCT: intensive court-ordered compulsory outpatient commitment versus 2. Standard care:
control group who were released from outpatient commitment by notifying the court.
Outcomes: no usable outcomes. Only the number of subsequent out-patient visits were reported, this was
considered to be inherent to the process of compulsory community treatment/outpatient commitment and
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not a result of the interventions
Wales 2006 Review: no primary data.
Xiao 2004 Allocation: not randomised.
Zanni 1986 Allocation: not randomised, no controls.
CCT - Compulsory community treatment
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D A T A A N D A N A L Y S E S
Comparison 1. COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Health service outcomes: 1.
Readmission to hospital - by
11-12 months
2 416 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.79, 1.21]
2 Health service outcomes: 2.
Compliance with medication -
by 11-12 months
2 416 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.83, 1.19]
3 Patient level outcomes: 1a. Social
functioning: trouble with
police - by 11-12 months
2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 at least one arrest 2 416 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.62, 1.52]
3.2 ever arrested/picked up by
police for violence against a
person
2 416 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.56, 1.21]
4 Patient level outcomes: 1b.
Social functioning: homeless -
by 11-12 months
2 416 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.39, 1.15]
5 Patient level outcomes: 2.
Quality of life: victimisation -
by 11-12 months
1 264 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
6 Patient level outcomes: 3.
Satisfaction with care: perceived
coercion - by 11-12 months
2 416 Risk Ratio (M-H, Fixed, 95% CI) 1.36 [0.97, 1.89]
Comparison 2. COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Health service outcomes: 1.
Readmission to hospital - by 12
months
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.74, 1.32]
2 Health service outcomes: 2.
Hospital bed-days
1 333 Mean Difference (IV, Fixed, 95% CI) -8.70 [-30.88, 13.
48]
3 Health service outcomes: 3.
Number of readmissions by 12
months
1 119 Mean Difference (IV, Fixed, 95% CI) -0.20 [-0.45, 0.05]
4 Health service outcomes:
4. Number with multiple
readmissions by 12 months
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.27, 1.17]
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5 Health service outcomes: 5.
Days in community till first
admission
1 333 Mean Difference (IV, Fixed, 95% CI) 5.0 [-21.74, 31.74]
6 Patient level outcomes: 1.
Mental state: BPRS
1 234 Mean Difference (IV, Fixed, 95% CI) -0.10 [-3.17, 2.97]
7 Patient level outcomes: 2. Global
state: GAF
1 237 Mean Difference (IV, Fixed, 95% CI) -0.70 [-3.91, 2.51]
Analysis 1.1. Comparison 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE, Outcome
1 Health service outcomes: 1. Readmission to hospital - by 11-12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome: 1 Health service outcomes: 1. Readmission to hospital - by 11-12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Steadman 2001 40/85 27/67 31.9 % 1.17 [ 0.81, 1.69 ]
Swartz 1999 56/129 66/135 68.1 % 0.89 [ 0.68, 1.15 ]
Total (95% CI) 214 202 100.0 % 0.98 [ 0.79, 1.21 ]
Total events: 96 (Treatment), 93 (Control)
Heterogeneity: Chi2 = 1.41, df = 1 (P = 0.23); I2 =29%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.2. Comparison 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE, Outcome
2 Health service outcomes: 2. Compliance with medication - by 11-12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome: 2 Health service outcomes: 2. Compliance with medication - by 11-12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Swartz 1999 54/129 55/135 50.6 % 1.03 [ 0.77, 1.37 ]
Steadman 2001 57/85 47/67 49.4 % 0.96 [ 0.77, 1.19 ]
Total (95% CI) 214 202 100.0 % 0.99 [ 0.83, 1.19 ]
Total events: 111 (Treatment), 102 (Control)
Heterogeneity: Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.3. Comparison 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE, Outcome
3 Patient level outcomes: 1a. Social functioning: trouble with police - by 11-12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome: 3 Patient level outcomes: 1a. Social functioning: trouble with police - by 11-12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 at least one arrest
Swartz 1999 19/129 22/135 65.8 % 0.90 [ 0.51, 1.59 ]
Steadman 2001 14/85 10/67 34.2 % 1.10 [ 0.52, 2.33 ]
Subtotal (95% CI) 214 202 100.0 % 0.97 [ 0.62, 1.52 ]
Total events: 33 (Treatment), 32 (Control)
Heterogeneity: Chi2 = 0.18, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
2 ever arrested/picked up by police for violence against a person
Swartz 1999 33/129 42/135 100.0 % 0.82 [ 0.56, 1.21 ]
Steadman 2001 0/85 0/67 Not estimable
Subtotal (95% CI) 214 202 100.0 % 0.82 [ 0.56, 1.21 ]
Total events: 33 (Treatment), 42 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.4. Comparison 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE, Outcome
4 Patient level outcomes: 1b. Social functioning: homeless - by 11-12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome: 4 Patient level outcomes: 1b. Social functioning: homeless - by 11-12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Swartz 1999 8/129 15/135 52.2 % 0.56 [ 0.24, 1.27 ]
Steadman 2001 12/85 12/67 47.8 % 0.79 [ 0.38, 1.64 ]
Total (95% CI) 214 202 100.0 % 0.67 [ 0.39, 1.15 ]
Total events: 20 (Treatment), 27 (Control)
Heterogeneity: Chi2 = 0.38, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.44 (P = 0.15)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.5. Comparison 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE, Outcome
5 Patient level outcomes: 2. Quality of life: victimisation - by 11-12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome: 5 Patient level outcomes: 2. Quality of life: victimisation - by 11-12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Swartz 1999 20/129 42/135 100.0 % 0.50 [ 0.31, 0.80 ]
Total (95% CI) 129 135 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 20 (Treatment), 42 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.88 (P = 0.0040)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.6. Comparison 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE, Outcome
6 Patient level outcomes: 3. Satisfaction with care: perceived coercion - by 11-12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 1 COMPULSORY COMMUNITY TREATMENT vs STANDARD CARE
Outcome: 6 Patient level outcomes: 3. Satisfaction with care: perceived coercion - by 11-12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Swartz 1999 37/129 27/135 58.1 % 1.43 [ 0.93, 2.21 ]
Steadman 2001 27/85 17/67 41.9 % 1.25 [ 0.75, 2.10 ]
Total (95% CI) 214 202 100.0 % 1.36 [ 0.97, 1.89 ]
Total events: 64 (Treatment), 44 (Control)
Heterogeneity: Chi2 = 0.16, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 1.81 (P = 0.071)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 2.1. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 1 Health service outcomes: 1. Readmission to hospital - by 12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 1 Health service outcomes: 1. Readmission to hospital - by 12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Burns 2013 59/166 60/167 100.0 % 0.99 [ 0.74, 1.32 ]
Total (95% CI) 166 167 100.0 % 0.99 [ 0.74, 1.32 ]
Total events: 59 (Treatment), 60 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours treatment Favours control
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Analysis 2.2. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 2 Health service outcomes: 2. Hospital bed-days.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 2 Health service outcomes: 2. Hospital bed-days
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burns 2013 166 82.2 (102) 167 90.9 (104.5) 100.0 % -8.70 [ -30.88, 13.48 ]
Total (95% CI) 166 167 100.0 % -8.70 [ -30.88, 13.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
-200 -100 0 100 200
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Analysis 2.3. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 3 Health service outcomes: 3. Number of readmissions by 12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 3 Health service outcomes: 3. Number of readmissions by 12 months
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burns 2013 59 1.2 (0.6) 60 1.4 (0.8) 100.0 % -0.20 [ -0.45, 0.05 ]
Total (95% CI) 59 60 100.0 % -0.20 [ -0.45, 0.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours treatment Favours control
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Analysis 2.4. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 4 Health service outcomes: 4. Number with multiple readmissions by 12 months.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 4 Health service outcomes: 4. Number with multiple readmissions by 12 months
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Burns 2013 10/166 18/167 100.0 % 0.56 [ 0.27, 1.17 ]
Total (95% CI) 166 167 100.0 % 0.56 [ 0.27, 1.17 ]
Total events: 10 (Treatment), 18 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours treatment Favours control
Analysis 2.5. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 5 Health service outcomes: 5. Days in community till first admission.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 5 Health service outcomes: 5. Days in community till first admission
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burns 2013 166 246 (122.4) 167 241 (126.5) 100.0 % 5.00 [ -21.74, 31.74 ]
Total (95% CI) 166 167 100.0 % 5.00 [ -21.74, 31.74 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 6 Patient level outcomes: 1. Mental state: BPRS.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 6 Patient level outcomes: 1. Mental state: BPRS
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burns 2013 122 38.2 (11.5) 112 38.3 (12.4) 100.0 % -0.10 [ -3.17, 2.97 ]
Total (95% CI) 122 112 100.0 % -0.10 [ -3.17, 2.97 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 2.7. Comparison 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE
(SECTION 17), Outcome 7 Patient level outcomes: 2. Global state: GAF.
Review: Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Comparison: 2 COMMUNITY TREATMENT ORDERS vs SUPERVISED DISCHARGE (SECTION 17)
Outcome: 7 Patient level outcomes: 2. Global state: GAF
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burns 2013 123 39 (12) 114 39.7 (13.1) 100.0 % -0.70 [ -3.91, 2.51 ]
Total (95% CI) 123 114 100.0 % -0.70 [ -3.91, 2.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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A P P E N D I C E S
Appendix 1. Search Strategies
2003 Searches
1. Cochrane Schizophrenia Group’s Register (May 2003)
We searched using the phrase:
[((community* AND treatment* AND order*) OR (involuntary* AND outpatient* AND treatment*) OR (involuntary* AND outpa-
tient* ANDcommitment*) OR (extended* AND leave*) in Title or (*community* AND *treatment* AND *order*)OR (*involuntary*
AND *outpatient* AND *treatment*) OR (*involuntary* AND *outpatient* AND *commitment*) OR (*extended* AND *leave*)
or (*supervised* AND *discharge*) in title, abstract, index terms of REFERENCE] or Involuntary Commitment in intervention of
STUDY)]
The Schizophrenia Groups trials register is based on regular searches of BIOSIS Inside; CENTRAL; CINAHL; EMBASE; MEDLINE
and PsycINFO; the hand searching of relevant journals and conference proceedings, and searches of several key grey literature sources.
A full description is given in the Group’s module.
2. Cochrane Library (Issue 2 2003)
We searched using the phrase:
[(expCommitment ofMentally Ill/ or (communityNEAR treatmentNEARorder) or (involuntaryNEARoutpatientNEAR treatment)
or (involuntary NEAR outpatient NEAR commitment) or (extended NEAR leave) or (supervised NEAR discharge)]
3. BIOSIS (1985 to July 2003)
We searched using the phrase:
[(Commitment ANDMentally AND Ill or (extended AND leave) or (community AND treatment AND order) or (involuntary AND
outpatient AND treatment) or (involuntary AND outpatient AND commitment) or (extended AND leave) or (supervised AND
discharge) or (mandatory AND programs))]
4. CINAHL (1982 to July 2003)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp Involuntary Commitment/ or exp Hospitalization/ or (extended adj1 leave) or (community adj2 treatment adj2 order) or exp
“NONCOMPLIANCE (NANDA)”/ or (involuntary adj3 outpatient adj3 treatment) or (involuntary adj3 outpatient adj3 commit-
ment) or (supervised adj2 discharge) or (mandatory adj3 programs) or (extended adj3 leave))
5. EMBASE (1980 to July 2003)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp Commitment of Mentally Ill/ or (extended adj1 leave) or (community adj2 treatment adj2 order) or (involuntary adj3 outpatient
adj3 treatment) or (involuntary adj3 outpatient adj3 commitment) or (extended adj3 leave) or (supervised adj2 discharge) or (mandatory
adj3 programs))
6. MEDLINE (1966 to July 2003)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp Commitment of Mentally Ill/ or jurisprudence/ or exp mandatory programs/ or (extended adj1 leave) or (community adj2
treatment adj2 order) or (involuntary adj3 outpatient adj3 treatment) or (involuntary adj3 outpatient adj3 commitment) or (extended
adj leave) or (extended adj3 leave) or (supervised adj2 discharge))
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7. PsycINFO (1872 to July 2003)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp outpatient commitment/ or exp Legal Processes/ or exp “Commitment (Psychiatric)”/ or exp Psychiatric Hospitalization/ or exp
Laws/ or exp Involuntary Treatment/ or (community adj2 treatment adj2 order) or (involuntary adj3 outpatient adj3 treatment) or
(involuntary adj3 outpatient adj3 commitment) or (extended adj3 leave) or (supervised adj2 discharge) or (mandatory adj3 programs))]
8. SCISEARCH
Science Citation Index: we sought each of the included studies as a citation on the SCISEARCH database. We then inspected reports
of articles that had cited these studies to identify further trials.
9. Google - Internet search engine (July 2003)
We searched the Internet to identify any relevant publications using the following terms:
community treatment order, involuntary outpatient treatment, involuntary outpatient commitment, extended leave, extended release
or supervised discharge.
2008 Searches
We searched the Cochrane Schizophrenia Group’s register using the phrase:
[(((*treatment* AND * order* within the same field) OR *(involuntar* AND *outpatient* within the same field) OR (*extend* AND
*leave* within the same field) OR (*supervis* AND *discharg* within the same field) OR (*compulsor* or *compulsion*) in title
abstract or index terms of REFERENCE) OR (*commitment of mentally ill* in index terms of REFERENCE) OR (Involuntary* OR
Outpatient* intervention of STUDY)]
This register is compiled by systematic searches of major databases, handsearches, and conference proceedings (see group module).
Additional searches by authors
1. Cochrane Library (Issue 2 2008)
We searched using the phrase:
[(expCommitment ofMentally Ill/ or (communityNEAR treatmentNEARorder) or (involuntaryNEARoutpatientNEAR treatment)
or (involuntary NEAR outpatient NEAR commitment) or (extended NEAR leave) or (supervised NEAR discharge)]
2. BIOSIS (1985 to December 2008)
We searched using the phrase:
[(Commitment ANDMentally AND Ill or (extended AND leave) or (community AND treatment AND order) or (involuntary AND
outpatient AND treatment) or (involuntary AND outpatient AND commitment) or (extended AND leave) or (supervised AND
discharge) or (mandatory AND programs))]
3. CINAHL (1982 to December 2008)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp Involuntary Commitment/ or exp Hospitalisation/ or (extended adj1 leave) or (community adj2 treatment adj2 order) or exp
“NONCOMPLIANCE (NANDA)”/ or (involuntary adj3 outpatient adj3 treatment) or (involuntary adj3 outpatient adj3 commit-
ment) or (supervised adj2 discharge) or (mandatory adj3 programs) or (extended adj3 leave))
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4. EMBASE (1980 to December 2008)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp Commitment of Mentally Ill/ or (extended adj1 leave) or (community adj2 treatment adj2 order) or (involuntary adj3 outpatient
adj3 treatment) or (involuntary adj3 outpatient adj3 commitment) or (extended adj3 leave) or (supervised adj2 discharge) or (mandatory
adj3 programs))
5. MEDLINE (1966 to December 2008)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp Commitment of Mentally Ill/ or jurisprudence/ or exp mandatory programs/ or (extended adj1 leave) or (community adj2
treatment adj2 order) or (involuntary adj3 outpatient adj3 treatment) or (involuntary adj3 outpatient adj3 commitment) or (extended
adj leave) or (extended adj3 leave) or (supervised adj2 discharge))
6. PsycINFO (1872 to December 2008)
We searched using the Cochrane Schizophrenia Group’s phrase for randomised controlled trials combined with:
[(exp outpatient commitment/ or exp Legal Processes/ or exp “Commitment (Psychiatric)”/ or exp Psychiatric Hospitalization/ or exp
Laws/ or exp Involuntary Treatment/ or (community adj2 treatment adj2 order) or (involuntary adj3 outpatient adj3 treatment) or
(involuntary adj3 outpatient adj3 commitment) or (extended adj3 leave) or (supervised adj2 discharge) or (mandatory adj3 programs))]
7. SCISEARCH - Science Citation Index
We sought each of the included studies as a citation on the SCISEARCH database. We then inspected reports of articles that had cited
these studies to identify further trials.
8. Google - Internet search engine (December 2008)
We searched the Internet to identify any relevant publications using the following terms:
community treatment order, involuntary outpatient treatment, involuntary outpatient commitment, extended leave, extended release
or supervised discharge.
Searching other resources
1. Reference searching
We also inspected the references of all identified studies (including those rejected from the review) for more studies.
2. Personal contact
We contacted the first author of each included study and known experts who had published reviews in the field for information
regarding unpublished trials and extra data on the published trials.
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Appendix 2. Previous data collection and analysis
1. Extraction
Authors SK and LAC independently extracted data from included studies. Again, we discussed any disagreement, documented our
decisions and, if necessary, we contacted the authors of studies for clarification. Whenever possible we only extracted data presented
in graphs and figures, we only included data if two review authors independently had the same result. We made attempts to contact
authors through an open-ended request in order to obtain any missing information or for clarification whenever necessary. Where
possible, we extracted data relevant to each component centre of multi-centre studies separately.
2. Management
2.1 Forms
SK and LAC extracted data onto standard, simple forms.
2.2 Data from multi-centre trials
Where possible the authors verified independently calculated centre data against original trial reports.
3. Rating scales
A wide range of instruments are available to measure outcomes in mental and physical health studies. They vary in quality and are often
not validated or are created for a particular study. It is accepted generally that measuring instruments should be both reliable and have
reasonable validity (Rust 1989). We included continuous data from rating scales only if the measuring instrument had been described
in a peer-reviewed journal (Marshall 2000); and not those written or modified by one of the trialists for a particular trial.
4. Endpoint versus change data
We preferred to use scale endpoint data, which typically cannot have negative values and are easier to interpret from a clinical point of
view. Change data are often not ordinal and are very problematic to interpret. If endpoint data were unavailable, we used change data.
5. Skewed data
Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests
to non-parametric data, we aim to apply the following standards to all data before inclusion: (a) standard deviations and means are
reported in the paper or obtainable from the authors; (b) when a scale starts from the finite number zero, the standard deviation,
when multiplied by two, is less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the
distribution, (Altman 1996); (c) if a scale starts from a positive value (such as PANSS which can have values from 30 to 210) the
calculation described above will be modified to take the scale starting point into account. In these cases skew is present if 2SD>(S-S
min), where S is the mean score and S min is the minimum score. Endpoint scores on scales often have a finite start and end point
and these rules can be applied. When continuous data are presented on a scale which includes a possibility of negative values (such as
change data), it is difficult to tell whether data are skewed or not. We entered skewed data from studies of fewer than 200 participants
in additional tables rather than into an analysis. Skewed data pose less of a problem when looking at means if the sample size is large,
and we entered skewed data from large sample sizes into syntheses.
6. Common measure
To facilitate comparison between trials, we intend to convert variables that can be reported in different metrics, such as days in hospital
(mean days per year, per week or per month) to a common metric (e.g. mean days per month).
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7. Conversion of continuous to binary
Where possible, we made efforts to convert outcome measures to dichotomous data. This could be done by identifying cut-off points
on rating scales and dividing participants accordingly into ’clinically improved’ or ’not clinically improved’. It was generally assumed
that if there had been a 50% reduction in a scale-derived score such as the Brief Psychiatric Rating Scale (BPRS, Overall 1962) or the
Positive and Negative Syndrome Scale (Kay 1986; Kay 1987), this could be considered as a clinically significant response (Leucht 2005;
Leucht 2005a). If data based on these thresholds were not available, we used the primary cut-off presented by the original authors.
8. Direction of graphs
Where possible, we entered data in such a way that the area to the left of the line of no effect indicates a favourable outcome for the
experimental intervention.
Assessment of risk of bias in included studies
Again working independently, two authors (SK, LAC) assessed risk of bias using the tool described in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2008) This tool encourages consideration of how the sequence was generated, how allocation
was concealed, the integrity of blinding at outcome, the completeness of outcome data, selective reporting, and other biases. We would
have excluded studies where allocation was clearly not concealed.
We removed trials with high risk of bias (defined as at least three out of six domains categorised as ’No’) from the ’included’ category.
If the raters disagreed, we made the final rating by consensus with the involvement of another member of the review group. Where
inadequate details of randomisation and other characteristics of trials are provided, we contacted authors of the studies in order to
obtain further information. We reported non-concurrence in quality assessment was reported.
Measures of treatment effect
1. Binary data
For binary outcomes we calculated a standard estimation of the fixed-effect risk ratio (RR) and its 95% confidence interval (CI) as
well as the number needed to treat/harm statistic (NNT/H). We calculated NNT using the methodology of Cook 1995 for the results
that were not significant. If statistically significant we took into account the event rate in the control group (Bandolier 1995). If we
found heterogeneity, then we made a decision about whether a quantitative synthesis (meta-analysis) was the appropriate method of
summarising this body of research and used a random-effects model.
2. Continuous data
For continuous outcomes we estimated a mean difference (MD) between groups. Again, if we found heterogeneity, then we made a
decision about whether a quantitative synthesis (meta-analysis) was the appropriate method of summarising this body of research and
used a random-effects model.
Unit of analysis issues
1. Cluster trials
We stated in our protocol (Kisely 2004) that we would account for cluster randomisation in our analysis. However, both studies
identified in our review were randomised by subject, not by clinician or practice. Studies increasingly employ ’cluster randomisation’
(such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to
account for intra class correlation in clustered studies, leading to a ’unit of analysis’ error (Divine 1992) whereby P values are spuriously
low, confidence intervals unduly narrow and statistical significance overestimated. This causes type I errors (Bland 1997; Gulliford
1999).
If clustering had not been accounted for in primary studies, we would have presented data in a table, with a (*) symbol to indicate
the presence of a probable unit of analysis error. In subsequent versions of this review we would have sought to contact first authors
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of studies to obtain intra class correlation co-efficient (ICC) of their clustered data and to adjust for this by using accepted methods
(Gulliford 1999). Should clustering have been incorporated into the analysis of primary studies, we would have presented these data
as if from a non-cluster randomised study, but adjusted for the clustering effect.
We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a ’design
effect’. This is calculated using the mean number of participants per cluster (m) and the ICC (Design effect=1+(m-1)*ICC) (Donner
2002). If the ICC had not been reported we would have assumed it to be 0.1 (Ukoumunne 1999).
If cluster studies had been appropriately analysed taking into account ICC and relevant data documented in the report, synthesis with
other studies would have been possible using the generic inverse variance technique.
2. Cross-over trials
A major concern of cross-over trials is the carry-over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological)
of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase, the participants
can differ systematically from their initial state despite a wash-out phase. For the same reason cross-over trials are not appropriate if the
condition of interest is unstable (Elbourne 2002). As both effects are very likely in serious mental illness, we would only have used data
of the first phase of cross-over studies.
3. Studies with multiple treatment groups
Where a study involved more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. Where
the additional treatment arms were not relevant, we did not reproduce these data.
Dealing with missing data
Reports of trials should give an adequate description of the loss of participants in terms of the number of withdrawals, dropouts,
and protocol deviations. We conducted an intention to treat analysis, including all those who were randomised to either compulsory
community treatment or control, regardless of subsequent disposition.
1. Overall loss of credibility
At some degree of loss of follow-up, data must lose credibility (Xia 2009). For any particular outcome, should more than 35% of data be
unaccounted for, we had stated that we would not reproduce these data or use them within analyses (Kisely 2004). However, the New
York study (Steadman 2001) reported attrition rates of approximately 45% for 11-month outcomes. As we were only able to identify
two RCTs, we decided to subject this high attrition study to a sensitivity analysis. If we found that inclusion of this data resulted in a
substantive change in the estimate of effect, we would not add them to results from Swartz 1999, but present them separately. This is
a considerable post hoc change from the original protocol (see Differences between protocol and review).
2. Binary
In the case where attrition for a binary outcome is between 0% and 50% and where these data were not clearly described, we presented
data on a ’once-randomised-always-analyse’ basis (an intention to treat analysis). Those lost to follow-up were all assumed to have
the same rates of negative outcome as those who completed, with the exception of the outcome of death. We undertook a sensitivity
analysis testing how prone the primary outcomes were to change when ’completed’ data only were compared to the intention to treat
analysis using the above assumption.
3. Continuous
3.1 Attrition
In the case where attrition for a continuous outcome is between 0% and 50% and completer-only data were reported, we have
reproduced these.
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3.2 Standard deviations
Where there are missing measures of variance for continuous data but exact standard error and confidence intervals are available for
group means, either P values or T values are available for differences in mean, we calculated standard deviation value according to
method described in Section 7.7.3 of theHandbook (Higgins 2008). If standard deviations were not reported and could not be calculated
from available data, we asked authors to supply the data. In the absence of data from authors, we used the mean standard deviation
from other studies.
3.3 Last observation carried forward
We anticipated that in some studies the method of last observation carried forward (LOCF) would be employed within the study
report. As with all methods of imputation to deal with missing data, LOCF introduces uncertainty about the reliability of the results.
Therefore, where LOCF data has been used in the trial, if less than 50% of the data had been assumed, we reproduced these data, and
indicated that they are the product of LOCF assumptions.
Assessment of heterogeneity
1. Clinical heterogeneity
To judge clinical heterogeneity, we considered all included studies, initially without seeing comparison data. We simply inspected all
studies for clearly outlying situations or people which we had not predicted would arise. Should such situations or participant groups
arise we will fully discuss these.
2. Methodological heterogeneity
We considered all included studies initially, without seeing comparison data, to judgemethodological heterogeneity.We simply inspected
all studies for clearly outlying methods which we had not predicted would arise. Should such methodological outliers arise we will fully
discuss these.
3. Statistical
3.1 Visual inspection
We visually inspected graphs to investigate the possibility of statistical heterogeneity.
3.2 Employing the I2 statistic
We investigated heterogeneity between studies by considering the I2 method alongside the Chi2 P value. The I2 provides an estimate of
the percentage of inconsistency thought to be due to chance (Higgins 2003). The importance of the observed value of I2 depends on i.
magnitude and direction of effects and ii. strength of evidence for heterogeneity (e.g. P value from Chi2 test, or a confidence interval
for I2).
We interpreted I2 estimate greater than or equal to 75% accompanied by a statistically significant Chi2 statistic as evidence of substantial
levels of heterogeneity (Section 9.5.2 - Higgins 2008) and explored reasons for heterogeneity. If the inconsistency was high and we
found clear reasons, we presented data separately.
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (Egger 1997).
These are described in Section 10 of the Handbook (Higgins 2008). We are aware that funnel plots may be useful in investigating
reporting biases but are of limited power to detect small-study effects. We did not use funnel plots for outcomes where there were 10
or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots were possible, we sought statistical advice
in their interpretation. Because there were never more than two studies for each outcome, we were unable to use this technique to
investigate publication/small study bias.
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Data synthesis
We understand that there is no closed argument for preference for use of fixed-effect or random-effects models. The random-effects
method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems
to be true to us and the random-effects model takes into account differences between studies even if there is no statistically significant
heterogeneity. There is, however, a disadvantage to the random-effects model. It puts added weight onto small studies which often are
the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. Therefore, we chose
the fixed-effect model for all analyses. The reader is, however, able to choose to inspect the data using the random model.
Subgroup analysis and investigation of heterogeneity
1. Subgroups
We had hoped to investigate subgroups including different variations of types of intervention (e.g. community treatment orders,
involuntary outpatient treatment, involuntary outpatient commitment or supervised discharge). Because there were never more than
two studies for each outcome, and all were of court-ordered compulsory community treatment, we could not undertake such sensitivity
analyses as we had hoped.
2. Investigation of heterogeneity
2.1 Unanticipated heterogeneity
Should unanticipated clinical or methodological heterogeneity have been obvious, we would have simply stated hypotheses regarding
these for future reviews or versions of this review. We did not anticipate undertaking analyses relating to these.
2.2 Anticipated heterogeneity
We did not anticipate specific reasons for heterogeneity.
Sensitivity analysis
We had anticipated undertaking a sensitivity analysis for primary outcomes should randomisation be implied rather than been stated
explicitly. This analysis was not necessary with the two included studies.
WH A T ’ S N E W
Last assessed as up-to-date: 13 November 2013.
Date Event Description
29 July 2014 New citation required but conclusions have not
changed
Data from one new included study (Burns 2013) have
not changed the overall conclusions of this review.
24 July 2014 Amended TSC checked the references/studies, added CRS IDs.
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(Continued)
2 December 2013 New search has been performed Updated search of 2012. One additional paper identi-
fied, which met expanded inclusion criteria. Results of
2012 and 2013 search assessed and added to review
H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 3, 2005
Date Event Description
27 July 2012 New search has been performed Update search of Cochrane Schizophrenia Group’s
Trial Register (see Search methods for identification
of studies), 5 studies identified, none of whichmet our
inclusion criteria
24 November 2010 New citation required but conclusions have not
changed
Review layout changed substantially to reflect new up-
dated Methods section
2 November 2009 New search has been performed Results of new search 2008 added, no new studies
added, conclusions not changed
Risk of bias table and Summary of Findings table
added.
22 October 2008 Amended Converted to new review format.
1 May 2003 New citation required and major changes First version underway.
C O N T R I B U T I O N S O F A U T H O R S
2012 and 2013 search
Steve Kisely (SK) - independently inspected citations from the new electronic search and identified relevant abstracts. SK also inspected
full articles of the abstracts meeting inclusion criteria. SK carried out the reliability check of all citations from the new electronic search,
updated results and discussion in light of new search.
Original review
Steve Kisely (SK) - formulated the review question, initially developed the search strategy, conducted the analysis, and wrote the first
draft of the review. SK also wrote the first draft of the updated review.
Leslie Anne Campbell (LAC) - reviewed and provided comments on the search strategy and review, conducted the analysis. She also
commented on the updated review.
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Health Outcomes Unit, Capital District Health Authority, Halifax, Canada.
• Dalhousie University, Halifax, Canada.
• Fremantle Hospital, Australia.
• University of Western Australia, Australia.
• University of Queensland, Australia.
Salary support of SK
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. Overall loss of credibility
We now think that the 35% cut-off was inadvisable and prefer 50%. However, this decision was taken only after seeing the data and
leaves all subsequent analyses very prone to the inclusion of bias (see Potential biases in the review process). We also added a comparison
of compulsory community treatment with supervised discharge.
2. Funnel plot
In our original protocol (Kisely 2004), we stated that data from all included studies would be entered into a funnel graph (trial effect
against trial size) in an attempt to investigate the likelihood of overt publication bias (Egger 1997). Because there were never more than
two studies for each outcome, we were unable to use this technique to investigate publication bias.
3. Updating of Methods and inclusion of ’Summary of findings’ and ’Risk of bias’ tables
In our protocol, we stated that we would only compare compulsory community treatment with standard voluntary care. However, the
scarcity of RCTs in the assessment of compulsory community treatment meant that we subsequently extended inclusion criteria to
studies that compared different types of compulsory treatment in the community.
In addition, we have added ’Risk of bias’ and a ’Summary of findings’ tables, as well as updated some of the methods and layout of text
to reflect the updated structure of Cochrane reviews.
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4. Outcome: Global state added
The new trial provided useable data from a Global State scale.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Ambulatory Care [standards; statistics & numerical data]; Commitment of Mentally Ill [∗legislation & jurisprudence]; Community
Mental Health Services [∗legislation & jurisprudence]; Crime Victims; Length of Stay [statistics & numerical data]; Mental Disorders
[∗therapy]; Patient Satisfaction; Randomized Controlled Trials as Topic; Treatment Outcome
MeSH check words
Humans
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